




Instance: composition-en-c73255ba16f112f8e9f93b50083ae06f
InstanceOf: CompositionUvEpi
Title: "Composition for prezista Package Leaflet"
Description:  "Composition for prezista Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/06/380/006"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpc73255ba16f112f8e9f93b50083ae06f)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - prezista"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  
  </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol type="1">
<li>What PREZISTA is and what it is used for</li>
<li>What you need to know before you take PREZISTA</li>
<li>How to take PREZISTA</li>
<li>Possible side effects</li>
<li>How to store PREZISTA</li>
<li>Contents of the pack and other information</li>
</ol>
 </div>"""   
          

* section[=].section[+]
  * title =  "1. What prezista is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What prezista is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is PREZISTA? PREZISTA contains the active substance darunavir.
PREZISTA is an antiretroviral medicine used in the treatment of Human
Immunodeficiency Virus (HIV) infection. It belongs to a group of
medicines called protease inhibitors. PREZISTA works by reducing the
amount of HIV in your body. This will improve your immune system and
reduces the risk of developing illnesses linked to HIV infection. What
it is used for? PREZISTA is used to treat HIV infected adults as well as
HIV infected children of 3 years of age and above, and at least 15
kilogram body weight (see How to take PREZISTA). PREZISTA must be taken
in combination with a low dose of cobicistat or ritonavir and other
anti-HIV medicines. Your doctor will discuss with you which combination
of medicines is best for you.</p>
 </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take prezista"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take prezista"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2 id="do-not-take-prezista">Do not take PREZISTA</h2>
<h2
id="if-you-are-allergic-to-darunavir-or-any-of-the-other-ingredients-of-this-medicine-listed-in-section-6-or-to-cobicistat-or-ritonavir">if
you are allergic to darunavir or any of the other ingredients of this
medicine (listed in section 6) or to cobicistat or ritonavir.</h2>
<h2
id="if-you-have-severe-liver-problems-ask-your-doctor-if-you-are-unsure-about-the-severity-of-your-liver-disease-some-additional-tests-might-be-necessary-tell-your-doctor-about-all-medicines-you-take-including-medicines-taken-orally-inhaled-injected-or-applied-to-the-skin-do-not-combine-prezista-with-any-of-the-following-medicines-if-you-are-taking-any-of-these-ask-your-doctor-about-switching-to-another-medicine-medicine-purpose-of-the-medicine-avanafil-to-treat-erectile-dysfunction-astemizole-or-terfenadine-to-treat-allergy-symptoms-triazolam-and-oral-taken-by-mouth-midazolam-to-help-you-sleep-andor-relieve-anxiety-cisapride-to-treat-some-stomach-conditions-colchicine-if-you-have-kidney-andor-liver-problems-to-treat-gout-or-familial-mediterranean-fever-lurasidone-pimozide-quetiapine-or-sertindole-to-treat-psychiatric-conditions-ergot-alkaloids-like-ergotamine-dihydroergotamine-ergometrine-and-methylergonovine-to-treat-migraine-headaches-amiodarone-bepridil-dronedarone-ivabradine-quinidine-ranolazine-to-treat-certain-heart-disorders-eg-abnormal-heart-beat-lovastatin-simvastatin-and-lomitapide-to-lower-cholesterol-levels-rifampicin-to-treat-some-infections-such-as-tuberculosis-the-combination-product-lopinavirritonavir-this-anti-hiv-medicine-belongs-to-the-same-class-as-prezista-elbasvirgrazoprevir-to-treat-hepatitis-c-infection-alfuzosin-to-treat-enlarged-prostate-sildenafil-to-treat-high-blood-pressure-in-the-pulmonary-circulation-ticagrelor-to-help-stop-the-clumping-of-platelets-in-the-treatment-of-patients-with-a-history-of-a-heart-attack-naloxegol-to-treat-opioid-induced-constipation-dapoxetine-to-treat-premature-ejaculation-domperidone-to-treat-nausea-and-vomiting-do-not-combine-prezista-with-products-that-contain-st-john-s-wort-hypericum-perforatum-warnings-and-precautions-talk-to-your-doctor-pharmacist-or-nurse-before-taking-prezista-prezista-is-not-a-cure-for-hiv-infection-people-taking-prezista-may-still-develop-infections-or-other-illnesses-associated-with-hiv-infection-you-must-keep-in-regular-contact-with-your-doctor-people-taking-prezista-may-develop-a-skin-rash-infrequently-a-rash-may-become-severe-or-potentially-life-threatening-please-contact-your-doctor-whenever-you-develop-a-rash-in-patients-taking-prezista-and-raltegravir-for-hiv-infection-rashes-generally-mild-or-moderate-may-occur-more-frequently-than-in-patients-taking-either-medicine-separately-tell-your-doctor-about-your-situation-before-and-during-your-treatment-make-sure-that-you-check-the-following-points-and-tell-your-doctor-if-any-of-these-apply-to-you">if
you have severe liver problems. Ask your doctor if you are unsure about
the severity of your liver disease. Some additional tests might be
necessary. Tell your doctor about all medicines you take including
medicines taken orally, inhaled, injected or applied to the skin. Do not
combine PREZISTA with any of the following medicines If you are taking
any of these, ask your doctor about switching to another medicine.
Medicine Purpose of the medicine Avanafil to treat erectile dysfunction
Astemizole or terfenadine to treat allergy symptoms Triazolam and oral
(taken by mouth) midazolam to help you sleep and/or relieve anxiety
Cisapride to treat some stomach conditions Colchicine (if you have
kidney and/or liver problems) to treat gout or familial Mediterranean
fever Lurasidone, pimozide, quetiapine or sertindole to treat
psychiatric conditions Ergot alkaloids like ergotamine,
dihydroergotamine, ergometrine and methylergonovine to treat migraine
headaches Amiodarone, bepridil, dronedarone, ivabradine, quinidine,
ranolazine to treat certain heart disorders e.g. abnormal heart beat
Lovastatin, simvastatin and lomitapide to lower cholesterol levels
Rifampicin to treat some infections such as tuberculosis The combination
product lopinavir/ritonavir this anti-HIV medicine belongs to the same
class as PREZISTA Elbasvir/grazoprevir to treat hepatitis C infection
Alfuzosin to treat enlarged prostate Sildenafil to treat high blood
pressure in the pulmonary circulation Ticagrelor to help stop the
clumping of platelets in the treatment of patients with a history of a
heart attack Naloxegol to treat opioid induced constipation Dapoxetine
to treat premature ejaculation Domperidone to treat nausea and vomiting
Do not combine PREZISTA with products that contain St John s Wort
(Hypericum perforatum). Warnings and precautions Talk to your doctor,
pharmacist or nurse before taking PREZISTA. PREZISTA is not a cure for
HIV infection. People taking PREZISTA may still develop infections or
other illnesses associated with HIV infection. You must keep in regular
contact with your doctor. People taking PREZISTA may develop a skin
rash. Infrequently a rash may become severe or potentially
life-threatening. Please contact your doctor whenever you develop a
rash. In patients taking PREZISTA and raltegravir (for HIV infection),
rashes (generally mild or moderate) may occur more frequently than in
patients taking either medicine separately. Tell your doctor about your
situation BEFORE and DURING your treatment Make sure that you check the
following points and tell your doctor if any of these apply to you.</h2>
<h2
id="tell-your-doctor-if-you-have-had-problems-with-your-liver-before-including-hepatitis-b-or-c-infection-your-doctor-may-evaluate-how-severe-your-liver-disease-is-before-deciding-if-you-can-take-prezista">Tell
your doctor if you have had problems with your liver before, including
hepatitis B or C infection. Your doctor may evaluate how severe your
liver disease is before deciding if you can take PREZISTA.</h2>
<h2
id="tell-your-doctor-if-you-have-diabetes-prezista-might-increase-sugar-levels-in-the-blood">Tell
your doctor if you have diabetes. PREZISTA might increase sugar levels
in the blood.</h2>
<h2
id="tell-your-doctor-immediately-if-you-notice-any-symptoms-of-infection-for-example-enlarged-lymph-nodes-and-fever-in-some-patients-with-advanced-hiv-infection-and-a-history-of-opportunistic-infection-signs-and-symptoms-of-inflammation-from-previous-infections-may-occur-soon-after-anti-hiv-treatment-is-started-it-is-believed-that-these-symptoms-are-due-to-an-improvement-in-the-body-s-immune-response-enabling-the-body-to-fight-infections-that-may-have-been-present-with-no-obvious-symptoms">Tell
your doctor immediately if you notice any symptoms of infection (for
example enlarged lymph nodes and fever). In some patients with advanced
HIV infection and a history of opportunistic infection, signs and
symptoms of inflammation from previous infections may occur soon after
anti-HIV treatment is started. It is believed that these symptoms are
due to an improvement in the body s immune response, enabling the body
to fight infections that may have been present with no obvious
symptoms.</h2>
<h2
id="in-addition-to-the-opportunistic-infections-autoimmune-disorders-a-condition-that-occurs-when-the-immune-system-attacks-healthy-body-tissue-may-also-occur-after-you-start-taking-medicines-for-the-treatment-of-your-hiv-infection-autoimmune-disorders-may-occur-many-months-after-the-start-of-treatment-if-you-notice-any-symptoms-of-infection-or-other-symptoms-such-as-muscle-weakness-weakness-beginning-in-the-hands-and-feet-and-moving-up-towards-the-trunk-of-the-body-palpitations-tremor-or-hyperactivity-please-inform-your-doctor-immediately-to-seek-necessary-treatment">In
addition to the opportunistic infections, autoimmune disorders (a
condition that occurs when the immune system attacks healthy body
tissue) may also occur after you start taking medicines for the
treatment of your HIV infection. Autoimmune disorders may occur many
months after the start of treatment. If you notice any symptoms of
infection or other symptoms such as muscle weakness, weakness beginning
in the hands and feet and moving up towards the trunk of the body,
palpitations, tremor or hyperactivity, please inform your doctor
immediately to seek necessary treatment.</h2>
<h2
id="tell-your-doctor-if-you-have-haemophilia-prezista-might-increase-the-risk-of-bleeding">Tell
your doctor if you have haemophilia. PREZISTA might increase the risk of
bleeding.</h2>
<h2
id="tell-your-doctor-if-you-are-allergic-to-sulphonamides-eg-used-to-treat-certain-infections">Tell
your doctor if you are allergic to sulphonamides (e.g. used to treat
certain infections).</h2>
<h2
id="tell-your-doctor-if-you-notice-any-musculoskeletal-problems-some-patients-taking-combination-antiretroviral-therapy-may-develop-a-bone-disease-called-osteonecrosis-death-of-bone-tissue-caused-by-loss-of-blood-supply-to-the-bone-the-length-of-combination-antiretroviral-therapy-corticosteroid-use-alcohol-consumption-severe-immunosuppression-higher-body-mass-index-among-others-may-be-some-of-the-many-risk-factors-for-developing-this-disease-signs-of-osteonecrosis-are-joint-stiffness-aches-and-pains-especially-of-the-hip-knee-and-shoulder-and-difficulty-in-movement-if-you-notice-any-of-these-symptoms-please-inform-your-doctor-elderly-prezista-has-only-been-used-in-limited-numbers-of-patients-65-years-or-older-if-you-belong-to-this-age-group-please-discuss-with-your-doctor-if-you-can-use-prezista-children-prezista-is-not-for-use-in-children-younger-than-3-years-of-age-or-weighing-less-than-15-kilograms-other-medicines-and-prezista-tell-your-doctor-or-pharmacist-if-you-are-taking-or-have-recently-taken-any-other-medicines-there-are-some-medicines-that-you-must-not-combine-with-prezista-these-are-mentioned-above-under-the-heading-do-not-combine-prezista-with-any-of-the-following-medicines-in-most-cases-prezista-can-be-combined-with-anti-hiv-medicines-belonging-to-another-class-eg-nrtis-nucleoside-reverse-transcriptase-inhibitors-nnrtis-non-nucleoside-reverse-transcriptase-inhibitors-ccr5-antagonists-and-fis-fusion-inhibitors-prezista-with-cobicistat-or-ritonavir-has-not-been-tested-with-all-pis-protease-inhibitors-and-must-not-be-used-with-other-hiv-pis-in-some-cases-dosage-of-other-medicines-might-need-to-be-changed-therefore-always-tell-your-doctor-if-you-take-other-anti-hiv-medicines-and-follow-your-doctor-s-instruction-carefully-on-which-medicines-can-be-combined-the-effects-of-prezista-might-be-reduced-if-you-take-any-of-the-following-products-tell-your-doctor-if-you-take">Tell
your doctor if you notice any musculoskeletal problems. Some patients
taking combination antiretroviral therapy may develop a bone disease
called osteonecrosis (death of bone tissue caused by loss of blood
supply to the bone). The length of combination antiretroviral therapy,
corticosteroid use, alcohol consumption, severe immunosuppression,
higher body mass index, among others, may be some of the many risk
factors for developing this disease. Signs of osteonecrosis are joint
stiffness, aches and pains (especially of the hip, knee and shoulder)
and difficulty in movement. If you notice any of these symptoms please
inform your doctor. Elderly PREZISTA has only been used in limited
numbers of patients 65 years or older. If you belong to this age group,
please discuss with your doctor if you can use PREZISTA. Children
PREZISTA is not for use in children younger than 3 years of age or
weighing less than 15 kilograms. Other medicines and PREZISTA Tell your
doctor or pharmacist if you are taking or have recently taken any other
medicines. There are some medicines that you must not combine with
PREZISTA. These are mentioned above under the heading Do not combine
PREZISTA with any of the following medicines: In most cases, PREZISTA
can be combined with anti-HIV medicines belonging to another class [e.g.
NRTIs (nucleoside reverse transcriptase inhibitors), NNRTIs
(non-nucleoside reverse transcriptase inhibitors), CCR5 antagonists and
FIs (fusion inhibitors)]. PREZISTA with cobicistat or ritonavir has not
been tested with all PIs (protease inhibitors) and must not be used with
other HIV PIs. In some cases dosage of other medicines might need to be
changed. Therefore always tell your doctor if you take other anti-HIV
medicines and follow your doctor s instruction carefully on which
medicines can be combined. The effects of PREZISTA might be reduced if
you take any of the following products. Tell your doctor if you
take:</h2>
<h2 id="phenobarbital-phenytoin-to-prevent-seizures">Phenobarbital,
phenytoin (to prevent seizures)</h2>
<h2 id="dexamethasone-corticosteroid">Dexamethasone
(corticosteroid)</h2>
<h2 id="efavirenz-hiv-infection">Efavirenz (HIV infection)</h2>
<h2
id="rifapentine-rifabutin-medicines-to-treat-some-infections-such-as-tuberculosis">Rifapentine,
rifabutin (medicines to treat some infections such as tuberculosis)</h2>
<h2
id="saquinavir-hiv-infection-the-effects-of-other-medicines-might-be-influenced-if-you-take-prezista-and-your-doctor-might-want-to-do-some-additional-blood-tests-tell-your-doctor-if-you-take">Saquinavir
(HIV infection). The effects of other medicines might be influenced if
you take PREZISTA and your doctor might want to do some additional blood
tests. Tell your doctor if you take:</h2>
<h2
id="amlodipine-diltiazem-disopyramide-carvedilol-felodipine-flecainide-lidocaine-metoprolol-mexiletine-nifedipine-nicardipine-propafenone-timolol-verapamil-for-heart-disease-as-the-therapeutic-effect-or-side-effects-of-these-medicines-may-be-increased">Amlodipine,
diltiazem, disopyramide, carvedilol, felodipine, flecainide, lidocaine,
metoprolol, mexiletine, nifedipine, nicardipine, propafenone, timolol,
verapamil (for heart disease) as the therapeutic effect or side effects
of these medicines may be increased.</h2>
<h2
id="apixaban-dabigatran-etexilate-edoxaban-rivaroxaban-warfarin-clopidogrel-to-reduce-clotting-of-the-blood-as-their-therapeutic-effect-or-side-effects-may-be-altered">Apixaban,
dabigatran etexilate, edoxaban, rivaroxaban, warfarin, clopidogrel (to
reduce clotting of the blood) as their therapeutic effect or side
effects may be altered.</h2>
<h2
id="oestrogen-based-hormonal-contraceptives-and-hormonal-replacement-therapy-prezista-might-reduce-its-effectiveness-when-used-for-birth-control-alternative-methods-of-non-hormonal-contraception-are-recommended">Oestrogen-based
hormonal contraceptives and hormonal replacement therapy. PREZISTA might
reduce its effectiveness. When used for birth control, alternative
methods of non-hormonal contraception are recommended.</h2>
<h2
id="ethinylestradioldrospirenone-prezista-might-increase-the-risk-for-elevated-potassium-levels-by-drospirenone">Ethinylestradiol/drospirenone.
PREZISTA might increase the risk for elevated potassium levels by
drospirenone.</h2>
<h2
id="atorvastatin-pravastatin-rosuvastatin-to-lower-cholesterol-levels-the-risk-of-muscle-damage-might-be-increased-your-doctor-will-evaluate-which-cholesterol-lowering-regimen-is-best-for-your-specific-situation">Atorvastatin,
pravastatin, rosuvastatin (to lower cholesterol levels). The risk of
muscle damage might be increased. Your doctor will evaluate which
cholesterol lowering regimen is best for your specific situation.</h2>
<h2 id="clarithromycin-antibiotic">Clarithromycin (antibiotic)</h2>
<h2
id="ciclosporin-everolimus-tacrolimus-sirolimus-for-dampening-down-your-immune-system-as-the-therapeutic-effect-or-side-effects-of-these-medicines-might-be-increased">Ciclosporin,
everolimus, tacrolimus, sirolimus (for dampening down your immune
system) as the therapeutic effect or side effects of these medicines
might be increased.</h2>
<h2
id="corticosteroids-including-betamethasone-budesonide-fluticasone-mometasone-prednisone-triamcinolone-these-medicines-are-used-to-treat-allergies-asthma-inflammatory-bowel-diseases-inflammatory-conditions-of-the-skin-eyes-joints-and-muscles-and-other-inflammatory-conditions-these-medicines-are-generally-taken-orally-inhaled-injected-or-applied-to-the-skin-if-alternatives-cannot-be-used-its-use-should-only-take-place-after-medical-evaluation-and-under-close-monitoring-by-your-doctor-for-corticosteroid-side-effects">Corticosteroids
including betamethasone, budesonide, fluticasone, mometasone,
prednisone, triamcinolone. These medicines are used to treat allergies,
asthma, inflammatory bowel diseases, inflammatory conditions of the
skin, eyes, joints and muscles and other inflammatory conditions. These
medicines are generally taken orally, inhaled, injected or applied to
the skin. If alternatives cannot be used, its use should only take place
after medical evaluation and under close monitoring by your doctor for
corticosteroid side effects.</h2>
<h2
id="buprenorphinenaloxone-medicines-to-treat-opioid-dependence">Buprenorphine/naloxone
(medicines to treat opioid dependence)</h2>
<h2 id="salmeterol-medicine-to-treat-asthma">Salmeterol (medicine to
treat asthma)</h2>
<h2
id="artemetherlumefantrine-a-combination-medicine-to-treat-malaria">Artemether/lumefantrine
(a combination medicine to treat malaria)</h2>
<h2
id="dasatinib-everolimus-irinotecan-nilotinib-vinblastine-vincristine-to-treat-cancer">Dasatinib,
everolimus, irinotecan, nilotinib, vinblastine, vincristine (to treat
cancer)</h2>
<h2
id="sildenafil-tadalafil-vardenafil-for-erectile-dysfunction-or-to-treat-a-heart-and-lung-disorder-called-pulmonary-arterial-hypertension">Sildenafil,
tadalafil, vardenafil (for erectile dysfunction or to treat a heart and
lung disorder called pulmonary arterial hypertension)</h2>
<h2
id="glecaprevirpibrentasvir-to-treat-hepatitis-c-infection">Glecaprevir/pibrentasvir
(to treat hepatitis C infection)</h2>
<h2 id="fentanyl-oxycodone-tramadol-to-treat-pain">Fentanyl, oxycodone,
tramadol (to treat pain)</h2>
<h2
id="fesoterodine-solifenacin-to-treat-urologic-disorders-your-doctor-might-want-to-do-some-additional-blood-tests-and-the-dosage-of-other-medicines-might-need-to-be-changed-since-either-their-own-or-prezista-s-therapeutic-effect-or-side-effects-may-be-influenced-when-combined-tell-your-doctor-if-you-take">Fesoterodine,
solifenacin (to treat urologic disorders). Your doctor might want to do
some additional blood tests and the dosage of other medicines might need
to be changed since either their own or PREZISTA s therapeutic effect or
side effects may be influenced when combined. Tell your doctor if you
take:</h2>
<h2
id="dabigatran-etexilate-edoxaban-warfarin-to-reduce-clotting-of-the-blood">Dabigatran
etexilate, edoxaban, warfarin (to reduce clotting of the blood)</h2>
<h2
id="alfentanil-injectable-strong-and-short-acting-painkiller-that-is-used-for-surgical-procedures">Alfentanil
(injectable strong and short-acting painkiller that is used for surgical
procedures)</h2>
<h2 id="digoxin-to-treat-certain-heart-disorders">Digoxin (to treat
certain heart disorders)</h2>
<h2 id="clarithromycin-antibiotic-1">Clarithromycin (antibiotic)</h2>
<h2
id="itraconazole-isavuconazole-fluconazole-posaconazole-clotrimazole-to-treat-fungal-infections-voriconazole-should-only-be-taken-after-medical-evaluation">Itraconazole,
isavuconazole, fluconazole, posaconazole, clotrimazole (to treat fungal
infections). Voriconazole should only be taken after medical
evaluation.</h2>
<h2 id="rifabutin-against-bacterial-infections">Rifabutin (against
bacterial infections)</h2>
<h2
id="sildenafil-vardenafil-tadalafil-for-erectile-dysfunction-or-high-blood-pressure-in-the-pulmonary-circulation">Sildenafil,
vardenafil, tadalafil (for erectile dysfunction or high blood pressure
in the pulmonary circulation)</h2>
<h2
id="amitriptyline-desipramine-imipramine-nortriptyline-paroxetine-sertraline-trazodone-to-treat-depression-and-anxiety">Amitriptyline,
desipramine, imipramine, nortriptyline, paroxetine, sertraline,
trazodone (to treat depression and anxiety)</h2>
<h2 id="maraviroc-to-treat-hiv-infection">Maraviroc (to treat HIV
infection)</h2>
<h2 id="methadone-to-treat-opiate-dependence">Methadone (to treat opiate
dependence)</h2>
<h2
id="carbamazepine-clonazepam-to-prevent-seizures-or-to-treat-certain-types-of-nerve-pain">Carbamazepine,
clonazepam (to prevent seizures or to treat certain types of nerve
pain)</h2>
<h2
id="colchicine-to-treat-gout-or-familial-mediterranean-fever">Colchicine
(to treat gout or familial Mediterranean fever)</h2>
<h2
id="bosentan-to-treat-high-blood-pressure-in-the-pulmonary-circulation">Bosentan
(to treat high blood pressure in the pulmonary circulation)</h2>
<h2
id="buspirone-clorazepate-diazepam-estazolam-flurazepam-midazolam-when-used-as-injection-zolpidem-sedative-agents">Buspirone,
clorazepate, diazepam, estazolam, flurazepam, midazolam when used as
injection, zolpidem (sedative agents)</h2>
<h2
id="perphenazine-risperidone-thioridazine-to-treat-psychiatric-conditions">Perphenazine,
risperidone, thioridazine (to treat psychiatric conditions)</h2>
<p>Metformin (to treat type 2 diabetes). This is not a complete list of
medicines. Tell your healthcare provider about all medicines that you
are taking. PREZISTA with food and drink See section 3 How to take
PREZISTA. Pregnancy and breast-feeding Tell your doctor immediately if
you are pregnant or planning to become pregnant. Pregnant women should
not take PREZISTA with ritonavir unless specifically directed by the
doctor. Pregnant women should not take PREZISTA with cobicistat. Because
of the potential for side effects in breast-fed infants, women should
not breast-feed if they are receiving PREZISTA. Breast-feeding is not
recommended in women living with HIV because HIV infection can be passed
on to the baby in breast milk. If you are breast-feeding, or thinking
about breast-feeding, you should discuss it with your doctor as soon as
possible. Driving and using machines Do not operate machines or drive if
you feel dizzy after taking PREZISTA. PREZISTA oral suspension contains
sodium methyl parahydroxybenzoate. This ingredient may cause allergic
reactions (sometimes delayed). PREZISTA contains sodium This medicine
contains less than 1 mmol sodium (23 mg) per ml, that is to say
essentially sodium-free .</p>
 </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take prezista"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take prezista"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2
id="always-use-this-medicine-exactly-as-described-in-this-leaflet-or-as-your-doctor-pharmacist-or-nurse-has-told-you-check-with-your-doctor-pharmacist-or-nurse-if-you-are-not-sure-even-if-you-feel-better-do-not-stop-taking-prezista-and-cobicistat-or-ritonavir-without-talking-to-your-doctor-after-therapy-has-been-initiated-the-dose-or-dosage-form-must-not-be-changed-or-therapy-must-not-be-stopped-without-instruction-of-the-doctor-dose-for-children-of-3-years-of-age-and-above-weighing-at-least-15-kilograms-who-have-not-taken-antiretroviral-medicines-before-your-child-s-doctor-will-determine-this-the-doctor-will-work-out-the-right-once-daily-dose-based-on-the-weight-and-age-of-the-child-see-table-below-this-dose-must-not-exceed-the-recommended-adult-dose-which-is-800-milligram-prezista-together-with-150-milligram-cobicistat-or-100-milligram-ritonavir-once-a-day-the-doctor-will-inform-you-on-how-much-prezista-oral-suspension-and-how-much-cobicistat-tablet-or-ritonavir-capsules-tablets-or-solution-the-child-must-take-weight-one-prezista-dose-is-one-ritonavira-dose-is-one-cobicistat-dose-is-between-15-and-30-kilograms-600-milligram-6-milliliter-100-milligram-12-milliliter-do-not-take-between-30-and-40-kilograms-675-milligram-68-milliliter-100-milligram-12-milliliter-do-not-take-more-than-40-kilograms-800-milligram-8-milliliter-100-milligram-12-milliliter-150-milligramb-a-ritonavir-oral-solution-80-milligram-per-milliliter-b-the-child-must-be-12-years-old-or-older-the-child-must-take-prezista-every-day-and-always-in-combination-with-150-milligram-cobicistat-or-100-milligram-of-ritonavir-and-with-food-prezista-cannot-work-properly-without-cobicistat-or-ritonavir-and-food-the-child-must-eat-a-meal-or-a-snack-within-30-minutes-prior-to-taking-prezista-and-either-cobicistat-or-ritonavir-the-type-of-food-is-not-important-your-child-s-doctor-will-determine-if-your-child-should-take-prezista-with-either-cobicistat-or-ritonavir-dose-for-children-of-3-years-of-age-and-above-weighing-at-least-15-kilograms-who-have-taken-antiretroviral-medicines-before-your-child-s-doctor-will-determine-this-the-doctor-will-work-out-the-right-dose-based-on-the-weight-and-age-of-the-child-see-table-below-the-doctor-will-determine-if-once-daily-dosing-or-twice-daily-dosing-is-appropriate-for-the-child-this-dose-must-not-exceed-the-recommended-adult-dose-which-is-600-milligram-prezista-together-with-100-milligram-ritonavir-two-times-per-day-or-800-milligram-prezista-together-with-150-milligram-cobicistat-or-100-milligram-ritonavir-once-a-day-the-doctor-will-inform-you-on-how-much-prezista-oral-suspension-and-how-much-cobicistat-tablet-or-ritonavir-capsules-tablets-or-solution-the-child-must-take-twice-daily-dosing-weight-one-prezista-dose-is-one-ritonavira-dose-is-between-15-and-30-kilograms-380-milligram-38-milliliter-50-milligram-06-milliliter-between-30-and-40-kilograms-460-milligram-46-milliliter-60-milligram-08-milliliter-more-than-40-kilograms-600-milligram-6-milliliter-100-milligram-12-milliliter-a-ritonavir-oral-solution-80-milligram-per-milliliter-once-daily-dosing-weight-one-prezista-dose-is-one-ritonavira-dose-is-one-cobicistat-dose-is-between-15-and-30-kilograms-600-milligram-6-milliliter-100-milligram-12-milliliter-do-not-take-between-30-and-40-kilograms-675-milligram-68-milliliter-100-milligram-12-milliliter-do-not-take-more-than-40-kilograms-800-milligram-8-milliliter-100-milligram-12-milliliter-150-milligramb-a-ritonavir-oral-solution-80-milligram-per-milliliter-b-the-child-must-be-12-years-old-or-older-instructions-for-children">Always
use this medicine exactly as described in this leaflet or as your
doctor, pharmacist or nurse has told you. Check with your doctor,
pharmacist or nurse if you are not sure. Even if you feel better, do not
stop taking PREZISTA and cobicistat or ritonavir without talking to your
doctor. After therapy has been initiated, the dose or dosage form must
not be changed or therapy must not be stopped without instruction of the
doctor. Dose for children of 3 years of age and above, weighing at least
15 kilograms who have not taken antiretroviral medicines before (your
child s doctor will determine this) The doctor will work out the right
once daily dose based on the weight and age of the child (see table
below). This dose must not exceed the recommended adult dose, which is
800 milligram PREZISTA together with 150 milligram cobicistat or 100
milligram ritonavir once a day. The doctor will inform you on how much
PREZISTA oral suspension and how much cobicistat (tablet) or ritonavir
(capsules, tablets or solution) the child must take. Weight One PREZISTA
dose is One ritonavira dose is One cobicistat dose is between 15 and 30
kilograms 600 milligram (6 milliliter) 100 milligram (1.2 milliliter) Do
not take between 30 and 40 kilograms 675 milligram (6.8 milliliter) 100
milligram (1.2 milliliter) Do not take more than 40 kilograms 800
milligram (8 milliliter) 100 milligram (1.2 milliliter) 150 milligramb a
ritonavir oral solution: 80 milligram per milliliter b the child must be
12 years old or older The child must take PREZISTA every day and always
in combination with 150 milligram cobicistat or 100 milligram of
ritonavir and with food. PREZISTA cannot work properly without
cobicistat or ritonavir and food. The child must eat a meal or a snack
within 30 minutes prior to taking PREZISTA and either cobicistat or
ritonavir. The type of food is not important. Your child s doctor will
determine if your child should take PREZISTA with either cobicistat or
ritonavir. Dose for children of 3 years of age and above, weighing at
least 15 kilograms who have taken antiretroviral medicines before (your
child s doctor will determine this) The doctor will work out the right
dose based on the weight and age of the child (see table below). The
doctor will determine if once daily dosing or twice daily dosing is
appropriate for the child. This dose must not exceed the recommended
adult dose, which is 600 milligram PREZISTA together with 100 milligram
ritonavir two times per day or 800 milligram PREZISTA together with 150
milligram cobicistat or 100 milligram ritonavir once a day. The doctor
will inform you on how much PREZISTA oral suspension and how much
cobicistat (tablet) or ritonavir (capsules, tablets or solution) the
child must take. Twice daily dosing Weight One PREZISTA dose is One
ritonavira dose is between 15 and 30 kilograms 380 milligram (3.8
milliliter) 50 milligram (0.6 milliliter) between 30 and 40 kilograms
460 milligram (4.6 milliliter) 60 milligram (0.8 milliliter) more than
40 kilograms 600 milligram (6 milliliter) 100 milligram (1.2 milliliter)
a ritonavir oral solution: 80 milligram per milliliter Once daily dosing
Weight One PREZISTA dose is One ritonavira dose is One cobicistat dose
is between 15 and 30 kilograms 600 milligram (6 milliliter) 100
milligram (1.2 milliliter) Do not take between 30 and 40 kilograms 675
milligram (6.8 milliliter) 100 milligram (1.2 milliliter) Do not take
more than 40 kilograms 800 milligram (8 milliliter) 100 milligram (1.2
milliliter) 150 milligramb a ritonavir oral solution: 80 milligram per
milliliter b the child must be 12 years old or older Instructions for
children</h2>
<h2
id="the-child-must-take-prezista-always-together-with-cobicistat-or-ritonavir-prezista-cannot-work-properly-without-cobicistat-or-ritonavir">The
child must take PREZISTA always together with cobicistat or ritonavir.
PREZISTA cannot work properly without cobicistat or ritonavir.</h2>
<h2
id="the-child-must-take-the-appropriate-doses-of-prezista-and-ritonavir-two-times-per-day-or-once-a-day-or-prezista-and-cobicistat-once-a-day-if-prescribed-prezista-twice-daily-the-child-must-take-one-dose-in-the-morning-and-one-dose-in-the-evening-your-child-s-doctor-will-determine-the-appropriate-dosing-regimen-for-your-child">The
child must take the appropriate doses of PREZISTA and ritonavir two
times per day or once a day or PREZISTA and cobicistat once a day. If
prescribed PREZISTA twice daily the child must take one dose in the
morning, and one dose in the evening. Your child s doctor will determine
the appropriate dosing regimen for your child.</h2>
<h2
id="the-child-must-take-prezista-with-food-prezista-cannot-work-properly-without-food-the-type-of-food-is-not-important-dose-for-adults-who-have-not-taken-antiretroviral-medicines-before-your-doctor-will-determine-this-the-usual-dose-of-prezista-is-800-milligram-once-daily-you-must-take-prezista-every-day-and-always-in-combination-with-150-milligram-of-cobicistat-or-100-milligram-of-ritonavir-and-with-food-prezista-cannot-work-properly-without-cobicistat-or-ritonavir-and-food-you-must-eat-a-meal-or-a-snack-within-30-minutes-prior-to-taking-your-prezista-and-cobicistat-or-ritonavir-the-type-of-food-is-not-important-even-if-you-feel-better-do-not-stop-taking-prezista-and-cobicistat-or-ritonavir-without-talking-to-your-doctor-dose-for-adults-who-have-taken-antiretroviral-medicines-before-your-doctor-will-determine-this-the-dose-is-either">The
child must take PREZISTA with food. PREZISTA cannot work properly
without food. The type of food is not important. Dose for adults who
have not taken antiretroviral medicines before (your doctor will
determine this) The usual dose of PREZISTA is 800 milligram once daily.
You must take PREZISTA every day and always in combination with 150
milligram of cobicistat or 100 milligram of ritonavir and with food.
PREZISTA cannot work properly without cobicistat or ritonavir and food.
You must eat a meal or a snack within 30 minutes prior to taking your
PREZISTA and cobicistat or ritonavir. The type of food is not important.
Even if you feel better, do not stop taking PREZISTA and cobicistat or
ritonavir without talking to your doctor. Dose for adults who have taken
antiretroviral medicines before (your doctor will determine this) The
dose is either:</h2>
<h2
id="600-milligram-prezista-together-with-100-milligram-ritonavir-twice-daily-or">600
milligram PREZISTA together with 100 milligram ritonavir twice daily.
OR</h2>
<h2
id="800-milligram-prezista-together-with-150-milligram-cobicistat-or-100-milligram-ritonavir-once-daily-please-discuss-with-your-doctor-which-dose-is-right-for-you-instructions-for-adults">800
milligram PREZISTA together with 150 milligram cobicistat or 100
milligram ritonavir once daily. Please discuss with your doctor which
dose is right for you. Instructions for adults</h2>
<h2
id="take-prezista-always-together-with-cobicistat-or-ritonavir-prezista-cannot-work-properly-without-cobicistat-or-ritonavir">Take
PREZISTA always together with cobicistat or ritonavir. PREZISTA cannot
work properly without cobicistat or ritonavir.</h2>
<p>Take PREZISTA with food. PREZISTA cannot work properly without food.
The type of food is not important. Instructions for use Use the dosing
pipette supplied with the pack to measure your dose accurately:</p>
<ol type="1">
<li>Shake the bottle well before each use.</li>
<li>Open the bottle of PREZISTA oral suspension by pushing downward on
the cap and twisting it counter-clockwise.</li>
<li>Insert the supplied oral dosing pipette all the way into the
bottle.</li>
<li>Pull the plunger until the top of the barrel meets the line that
matches the dose prescribed by your healthcare provider.</li>
<li>Take the dose of PREZISTA. Place the tip of the oral dosing pipette
in the mouth. Press on the plunger of the pipette towards the mouth,
then swallow.</li>
<li>Close the bottle with the cap after use, and store PREZISTA oral
suspension as directed in section 5 below.</li>
<li>Remove the plunger from the barrel of the pipette, rinse both with
water and allow to air dry after each use.</li>
<li>Put the oral dosing pipette back together after air drying and store
with the PREZISTA bottle. Do not use the dosing pipette for any other
medicines. If you take more PREZISTA than you should Contact your
doctor, pharmacist or nurse immediately. If you forget to take PREZISTA
If you take PREZISTA two times a day and if you notice within 6 hours,
you must take the oral suspension immediately. Always take with
ritonavir and food. If you notice after 6 hours, then skip the intake
and take the next doses as usual. Do not take a double dose to make up
for a forgotten dose. If you take PREZISTA once a day and if you notice
within 12 hours, you must take the oral suspension immediately. Always
take with cobicistat or ritonavir and food. If you notice after 12
hours, then skip the intake and take the next doses as usual. Do not
take a double dose to make up for a forgotten dose. If you vomit after
taking PREZISTA and cobicistat or ritonavir If you vomit within 4 hours
of taking the medicine, another dose of PREZISTA and cobicistat or
ritonavir should be taken with food as soon as possible. If you vomit
more than 4 hours after taking the medicine, then you do not need to
take another dose of PREZISTA and cobicistat or ritonavir until the next
regularly scheduled time. Contact your doctor if you are uncertain about
what to do if you miss a dose or vomit. Do not stop taking PREZISTA
without talking to your doctor first Anti-HIV medicines may make you
feel better. Even when you feel better, do not stop taking PREZISTA.
Talk to your doctor first. If you have any further questions on the use
of this medicine, ask your doctor, pharmacist or nurse.</li>
</ol>
 </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2
id="during-hiv-therapy-there-may-be-an-increase-in-weight-and-in-levels-of-blood-lipids-and-glucose-this-is-partly-linked-to-restored-health-and-life-style-and-in-the-case-of-blood-lipids-sometimes-to-the-hiv-medicines-themselves-your-doctor-will-test-for-these-changes-like-all-medicines-this-medicine-can-cause-side-effects-although-not-everybody-gets-them-tell-your-doctor-if-you-develop-any-of-the-following-side-effects-liver-problems-that-may-occasionally-be-severe-have-been-reported-your-doctor-should-do-blood-tests-before-you-start-prezista-if-you-have-chronic-hepatitis-b-or-c-infection-your-doctor-should-check-your-blood-tests-more-often-because-you-have-an-increased-chance-of-developing-liver-problems-talk-to-your-doctor-about-the-signs-and-symptoms-of-liver-problems-these-may-include-yellowing-of-your-skin-or-whites-of-your-eyes-dark-tea-coloured-urine-pale-coloured-stools-bowel-movements-nausea-vomiting-loss-of-appetite-or-pain-aching-or-pain-and-discomfort-on-your-right-side-below-your-ribs-skin-rash-more-often-when-used-in-combination-with-raltegravir-itching-the-rash-is-usually-mild-to-moderate-a-skin-rash-might-also-be-a-symptom-of-a-rare-severe-situation-it-is-important-to-talk-to-your-doctor-if-you-develop-a-rash-your-doctor-will-advise-you-how-to-deal-with-your-symptoms-or-whether-prezista-must-be-stopped-other-severe-side-effects-were-diabetes-common-and-inflammation-of-the-pancreas-uncommon-very-common-side-effects-may-affect-more-than-1-in-10-people">During
HIV therapy there may be an increase in weight and in levels of blood
lipids and glucose. This is partly linked to restored health and life
style, and in the case of blood lipids sometimes to the HIV medicines
themselves. Your doctor will test for these changes. Like all medicines,
this medicine can cause side effects, although not everybody gets them.
Tell your doctor if you develop any of the following side effects Liver
problems that may occasionally be severe have been reported. Your doctor
should do blood tests before you start PREZISTA. If you have chronic
hepatitis B or C infection, your doctor should check your blood tests
more often because you have an increased chance of developing liver
problems. Talk to your doctor about the signs and symptoms of liver
problems. These may include yellowing of your skin or whites of your
eyes, dark (tea coloured) urine, pale coloured stools (bowel movements),
nausea, vomiting, loss of appetite, or pain, aching, or pain and
discomfort on your right side below your ribs. Skin rash (more often
when used in combination with raltegravir), itching. The rash is usually
mild to moderate. A skin rash might also be a symptom of a rare severe
situation. It is important to talk to your doctor if you develop a rash.
Your doctor will advise you how to deal with your symptoms or whether
PREZISTA must be stopped. Other severe side effects were diabetes
(common) and inflammation of the pancreas (uncommon). Very common side
effects (may affect more than 1 in 10 people)</h2>
<h2
id="diarrhoea-common-side-effects-may-affect-up-to-1-in-10-people">diarrhoea.
Common side effects (may affect up to 1 in 10 people)</h2>
<h2
id="vomiting-nausea-abdominal-pain-or-distension-dyspepsia-flatulence">vomiting,
nausea, abdominal pain or distension, dyspepsia, flatulence</h2>
<h2
id="headache-tiredness-dizziness-drowsiness-numbness-tingling-or-pain-in-hands-or-feet-loss-of-strength-difficulty-falling-asleep-uncommon-side-effects-may-affect-up-to-1-in-100-people">headache,
tiredness, dizziness, drowsiness, numbness, tingling or pain in hands or
feet, loss of strength, difficulty falling asleep. Uncommon side effects
(may affect up to 1 in 100 people)</h2>
<h2
id="chest-pain-changes-in-electrocardiogram-rapid-heart-beating">chest
pain, changes in electrocardiogram, rapid heart beating</h2>
<h2
id="decreased-or-abnormal-skin-sensibility-pins-and-needles-attention-disturbance-loss-of-memory-problems-with-your-balance">decreased
or abnormal skin sensibility, pins and needles, attention disturbance,
loss of memory, problems with your balance</h2>
<h2
id="difficulty-breathing-cough-nosebleed-throat-irritation">difficulty
breathing, cough, nosebleed, throat irritation</h2>
<h2
id="inflammation-of-the-stomach-or-mouth-heartburn-retching-dry-mouth-discomfort-of-the-abdomen-constipation-belching">inflammation
of the stomach or mouth, heartburn, retching, dry mouth, discomfort of
the abdomen, constipation, belching</h2>
<h2
id="kidney-failure-kidney-stones-difficult-discharge-of-urine-frequent-or-excessive-passage-of-urine-sometimes-at-night">kidney
failure, kidney stones, difficult discharge of urine, frequent or
excessive passage of urine, sometimes at night</h2>
<h2
id="urticaria-severe-swelling-of-the-skin-and-other-tissues-most-often-the-lips-or-the-eyes-eczema-excessive-sweating-night-sweats-hair-loss-acne-scaly-skin-colouration-of-nails">urticaria,
severe swelling of the skin and other tissues (most often the lips or
the eyes), eczema, excessive sweating, night sweats, hair loss, acne,
scaly skin, colouration of nails</h2>
<h2
id="muscle-pain-muscle-cramps-or-weakness-pain-in-extremity-osteoporosis">muscle
pain, muscle cramps or weakness, pain in extremity, osteoporosis</h2>
<h2
id="slowing-down-of-the-thyroid-gland-function-this-can-be-seen-in-a-blood-test">slowing
down of the thyroid gland function. This can be seen in a blood
test.</h2>
<h2 id="high-blood-pressure-flushing">high blood pressure, flushing</h2>
<h2 id="red-or-dry-eyes">red or dry eyes</h2>
<h2
id="fever-swelling-of-lower-limbs-due-to-fluids-malaise-irritability-pain">fever,
swelling of lower limbs due to fluids, malaise, irritability, pain</h2>
<h2 id="symptoms-of-infection-herpes-simplex">symptoms of infection,
herpes simplex</h2>
<h2 id="erectile-dysfunction-enlargement-of-breasts">erectile
dysfunction, enlargement of breasts</h2>
<h2
id="sleeping-problems-sleepiness-depression-anxiety-abnormal-dreams-decrease-in-sexual-drive-rare-side-effects-may-affect-up-to-1-in-1000-people">sleeping
problems, sleepiness, depression, anxiety, abnormal dreams, decrease in
sexual drive Rare side effects (may affect up to 1 in 1,000 people)</h2>
<h2
id="a-reaction-called-dress-severe-rash-which-may-be-accompanied-by-fever-fatigue-swelling-of-the-face-or-lymph-glands-increase-of-eosinophils-type-of-white-blood-cells-effects-on-liver-kidney-or-lung">a
reaction called DRESS [severe rash, which may be accompanied by fever,
fatigue, swelling of the face or lymph glands, increase of eosinophils
(type of white blood cells), effects on liver, kidney or lung]</h2>
<h2 id="heart-attack-slow-heart-beating-palpitations">heart attack, slow
heart beating, palpitations</h2>
<h2 id="visual-disturbance">visual disturbance</h2>
<h2 id="chills-feeling-abnormal">chills, feeling abnormal</h2>
<h2
id="a-feeling-of-confusion-or-disorientation-altered-mood-restlessness">a
feeling of confusion or disorientation, altered mood, restlessness</h2>
<h2 id="fainting-epileptic-fits-changes-or-loss-of-taste">fainting,
epileptic fits, changes or loss of taste</h2>
<h2
id="mouth-sores-vomiting-blood-inflammation-of-the-lips-dry-lips-coated-tongue">mouth
sores, vomiting blood, inflammation of the lips, dry lips, coated
tongue</h2>
<h2 id="running-nose">running nose</h2>
<h2 id="skin-lesions-dry-skin">skin lesions, dry skin</h2>
<h2
id="stiffness-of-muscles-or-joints-joint-pain-with-or-without-inflammation">stiffness
of muscles or joints, joint pain with or without inflammation</h2>
<h2
id="changes-in-some-values-of-your-blood-cells-or-chemistry-these-can-be-seen-in-the-results-of-blood-andor-urine-tests-your-doctor-will-explain-these-to-you-examples-are-increase-in-some-white-blood-cells">changes
in some values of your blood cells or chemistry. These can be seen in
the results of blood and/or urine tests. Your doctor will explain these
to you. Examples are: increase in some white blood cells</h2>
<h2
id="darunavir-crystals-in-the-kidney-causing-kidney-disease-some-side-effects-are-typical-for-anti-hiv-medicines-in-the-same-family-as-prezista-these-are">darunavir
crystals in the kidney causing kidney disease. Some side effects are
typical for anti-HIV medicines in the same family as PREZISTA. These
are:</h2>
<p>muscle pain, tenderness or weakness. On rare occasions, these muscle
disorders have been serious. Reporting of side effects If you get any
side effects, talk to your doctor, pharmacist or nurse. This includes
any possible side effects not listed in this leaflet. You can also
report side effects directly via the national reporting system listed in
Appendix V. By reporting side effects you can help provide more
information on the safety of this medicine.</p>
 </div>"""      
        
* section[=].section[+]
  * title = "5. How to store prezista"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store prezista"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. Do not use
this medicine after the expiry date which is stated on the carton and on
the bottle after EXP. The expiry date refers to the last day of that
month. Do not store above 30 C. Do not refrigerate or freeze. Avoid
exposure to excessive heat. Store in the original container. Do not
throw away any medicines via wastewater or household waste. Ask your
pharmacist how to throw away any medicines you no longer use. These
measures will help protect the environment.</p>
 </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2 id="what-prezista-contains">What PREZISTA contains</h2>
<h2
id="the-active-substance-is-darunavir-each-milliliter-contains-100-milligram-of-darunavir-as-ethanolate">The
active substance is darunavir. Each milliliter contains 100 milligram of
darunavir (as ethanolate).</h2>
<p>The other ingredients are hydroxypropyl cellulose, microcrystalline
cellulose and carmellose sodium, citric acid monohydrate, sucralose,
strawberry cream flavour, masking flavour, sodium methyl
parahydroxybenzoate (E219), hydrochloric acid (for pH adjustment),
purified water. What PREZISTA looks like and contents of the pack White
to off-white opaque oral suspension. Provided in a 200 ml amber glass
bottle with polypropylene child resistant closure and a 6 ml low density
polyethylene (LDPE) oral dosing pipette with 0.2 ml gradations. The
bottle neck is filled with a low density polyethylene (LDPE) insert that
accommodates the dosing pipette. Do not use the oral dosing pipette for
any other medicines. PREZISTA is also available as 75 milligram, 150
milligram, 400 milligram, 600 milligram and 800 milligram film-coated
tablets. Marketing Authorisation Holder Janssen-Cilag International NV,
Turnhoutseweg 30, B-2340 Beerse, Belgium Manufacturer Janssen
Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium For any
information about this medicine, please contact the local representative
of the Marketing Authorisation Holder: Belgi /Belgique/Belgien
Janssen-Cilag NV Tel/T l: +32 14 64 94 <a
href="mailto:janssen@jacbe.jnj.com">janssen@jacbe.jnj.com</a> Lietuva
UAB "JOHNSON &amp; JOHNSON" Tel: +370 5 278 68 <a
href="mailto:lt@its.jnj.com">lt@its.jnj.com</a></p>
<p>&amp;<br />
.: +359 2 489 94 <a
href="mailto:jjsafety@its.jnj.com">jjsafety@its.jnj.com</a>
Luxembourg/Luxemburg Janssen-Cilag NV T l/Tel: +32 14 64 94 <a
href="mailto:janssen@jacbe.jnj.com">janssen@jacbe.jnj.com</a> esk
republika Janssen-Cilag s.r.o. Tel: +420 227 012 Magyarorsz g
Janssen-Cilag Kft. Tel.: +36 1 884 <a
href="mailto:2janssenhu@its.jnj.com">2janssenhu@its.jnj.com</a> Danmark
Janssen-Cilag A/S Tlf: +45 4594 <a
href="mailto:8jacdk@its.jnj.com">8jacdk@its.jnj.com</a> Malta AM MANGION
LTD Tel: +356 2397 6Deutschland Janssen-Cilag GmbH Tel: +49 2137 955 <a
href="mailto:jancil@its.jnj.com">jancil@its.jnj.com</a> Nederland
Janssen-Cilag B.V. Tel: +31 76 711 <a
href="mailto:1janssen@jacnl.jnj.com">1janssen@jacnl.jnj.com</a> Eesti
UAB "JOHNSON &amp; JOHNSON" Eesti filiaal Tel: +372 617 <a
href="mailto:7ee@its.jnj.com">7ee@its.jnj.com</a> Norge Janssen-Cilag AS
Tlf: +47 24 12 65 <a
href="mailto:jacno@its.jnj.com">jacno@its.jnj.com</a></p>
<p>Janssen-Cilag . . . . T : +30 210 80 90 sterreich Janssen-Cilag
Pharma GmbH Tel: +43 1 610 Espa a Janssen-Cilag, S.A. Tel: +34 91 722 81
<a href="mailto:contacto@its.jnj.com">contacto@its.jnj.com</a> Polska
Janssen-Cilag Polska Sp. z o.o. Tel.: +48 22 237 60 France Janssen-Cilag
T l: 0 800 25 50 75 / +33 1 55 00 40 <a
href="mailto:medisource@its.jnj.com">medisource@its.jnj.com</a> Portugal
Janssen-Cilag Farmac utica, Lda. Tel: +351 214 368 Hrvatska Johnson
&amp; Johnson S.E. d.o.o. Tel: +385 1 6610 <a
href="mailto:jjsafety@JNJCR.JNJ.com">jjsafety@JNJCR.JNJ.com</a> Rom nia
Johnson &amp; Johnson Rom nia SRL Tel: +40 21 207 1Ireland Janssen
Sciences Ireland UC Tel: +353 1 800 709 Slovenija Johnson &amp; Johnson
d.o.o. Tel: +386 1 401 18 <a
href="mailto:Janssen_safety_slo@its.jnj.com">Janssen_safety_slo@its.jnj.com</a>
sland Janssen-Cilag AB c/o Vistor hf. S mi: +354 535 <a
href="mailto:7janssen@vistor.is">7janssen@vistor.is</a> Slovensk
republika Johnson &amp; Johnson, s.r.o. Tel: +421 232 408 Italia
Janssen-Cilag SpA Tel: 800.688.777 / +39 02 2510 1 <a
href="mailto:janssenita@its.jnj.com">janssenita@its.jnj.com</a>
Suomi/Finland Janssen-Cilag Oy Puh/Tel: +358 207 531 <a
href="mailto:jacfi@its.jnj.com">jacfi@its.jnj.com</a></p>
<p>: +357 22 207 Sverige Janssen-Cilag AB Tfn: +46 8 626 50 <a
href="mailto:jacse@its.jnj.com">jacse@its.jnj.com</a> Latvija UAB
"JOHNSON &amp; JOHNSON" fili le Latvij Tel: +371 678 <a
href="mailto:93lv@its.jnj.com">93lv@its.jnj.com</a> United Kingdom
(Northern Ireland) Janssen Sciences Ireland UC Tel: +44 1 494 567 This
leaflet was last revised in {MM/YYYY}. Detailed information on this
medicine is available on the European Medicines Agency web site:</p>
 </div>"""      



Instance: composition-da-c73255ba16f112f8e9f93b50083ae06f
InstanceOf: CompositionUvEpi
Title: "Composition for prezista Package Leaflet"
Description:  "Composition for prezista Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/06/380/006"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpc73255ba16f112f8e9f93b50083ae06f)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - prezista"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. INDLGSSEDDEL"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. INDLGSSEDDEL"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Indlgsseddel: Information til brugeren"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Indlgsseddel: Information til brugeren"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  
  </div>"""   



* section[=].section[+]
  * title = "Oversigt over indlgssedlen"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Oversigt over indlgssedlen"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlgssedlen:</p>
<ol type="1">
<li>Virkning og anvendelse</li>
<li>Det skal du vide, fr du begynder at tage PREZISTA</li>
<li>Sdan skal du tage PREZISTA</li>
<li>Bivirkninger</li>
<li>Opbevaring</li>
<li>Pakningsstrrelser og yderligere oplysninger</li>
</ol>
 </div>"""   
          

* section[=].section[+]
  * title =  "1. Virkning og anvendelse"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. Virkning og anvendelse"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Hvad er PREZISTA? PREZISTA indeholder det aktive stof darunavir.
PREZISTA er et lgemiddel, som forhindrer virus af typen retrovirus i at
formere sig (antiretroviralt lgemiddel). PREZISTA anvendes til
behandling af hiv-infektion (hiv: humant immundefektvirus). Det tilhrer
den lgemiddelgruppe, der kaldes proteasehmmere. PREZISTA virker ved at
reducere mngden af hiv i kroppen. Dette forbedrer immunforsvaret og
nedstter risikoen for at udvikle sygdomme, der er forbundet med
hiv-infektion. Hvad anvendes det til? PREZISTA anvendes til at behandle
hiv-infektion hos voksne samt hos brn fra 3 r og opefter med en
legemsvgt p mindst 15 kg (se Sdan skal du tage PREZISTA). PREZISTA
skal tages i kombination med en lavdosis cobicistat eller ritonavir og
anden hiv-medicin. Din lge vil fortlle dig, hvilken
medicinkombination, der er bedst for dig.</p>
 </div>"""   
          

             
* section[=].section[+]
  * title = "2. Det skal du vide, fr du begynder at tage  prezista"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. Det skal du vide, fr du begynder at tage  prezista"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2 id="tag-ikke-prezista">Tag ikke PREZISTA</h2>
<h2
id="hvis-du-er-allergisk-over-for-darunavir-eller-et-af-de-vrige-indholdsstoffer-i-prezista-angivet-i-punkt-6-eller-over-for-cobicistat-eller-ritonavir">hvis
du er allergisk over for darunavir eller et af de vrige indholdsstoffer
i PREZISTA (angivet i punkt 6) eller over for cobicistat eller
ritonavir.</h2>
<h2
id="hvis-du-har-alvorlige-leverproblemer-du-skal-sprge-din-lge-hvis-du-ikke-er-sikker-p-hvor-alvorlig-din-leversygdom-er-det-kan-vre-ndvendigt-at-foretage-yderligere-test-fortl-lgen-om-alle-lgemidler-du-tager-herunder-medicin-som-du-tager-gennem-munden-inhalerer-indsprjter-eller-pfrer-p-huden-du-m-ikke-tage-prezista-sammen-med-flgende-medicin-hvis-du-tager-et-af-disse-lgemidler-skal-du-tale-med-din-lge-om-at-skifte-til-en-anden-medicin-144-medicin-formlet-med-medicinen-avanafil-til-behandling-af-impotens-astemizol-eller-terfenadin-til-behandling-af-symptomer-p-allergi-triazolam-eller-midazolam-indtaget-gennem-munden-som-sovemiddel-ogeller-til-at-afhjlpe-angst-cisaprid-til-behandling-af-visse-mavelidelser-colchicin-hvis-du-har-problemer-med-nyrerne-ogeller-leveren-til-behandling-af-urinsur-gigt-eller-familir-middelhavsfeber-lurasidon-pimozid-quetiapin-eller-sertindol-til-behandling-af-psykiske-lidelser-sekalealkaloider-feks-ergotamin-dihydroergotamin-ergometrin-og-methylergometrin-til-behandling-af-migrnehovedpine-amiodaron-bepridil-dronedaron-ivabradin-kinidin-ranolazin-til-behandling-af-visse-hjertelidelser-som-feks-unormal-hjerterytme-lovastatin-simvastatin-og-lomitapid-til-nedsttelse-af-kolesterol-i-blodet-rifampicin-til-behandling-af-visse-infektioner-ssom-tuberkulose-kombinationsproduktet-lopinavirritonavir-denne-medicin-mod-hiv-tilhrer-samme-gruppe-som-prezista-elbasvirgrazoprevir-til-behandling-af-hepatitis-c-infektion-alfuzosin-til-behandling-af-forstrret-blrehalskirtel-prostata-sildenafil-til-behandling-af-for-hjt-blodtryk-i-lungekredslbet-ticagrelor-som-hjlp-til-at-hindre-sammenklumpning-af-blodplader-hos-patienter-der-tidligere-har-haft-et-hjerteanfald-naloxegol-til-behandling-af-forstoppelse-forrsaget-af-opioidbehandling-dapoxetin-til-behandling-af-for-tidlig-sdafgang-domperidon-til-behandling-af-kvalme-og-opkastning-prezista-m-ikke-kombineres-med-naturlgemidler-der-indeholder-perikon-hypericum-perforatum-advarsler-og-forsigtighedsregler-kontakt-lgen-apotekspersonalet-eller-sygeplejersken-fr-du-tager-prezista-prezista-kan-ikke-helbrede-hiv-infektion-personer-der-tager-prezista-kan-stadig-udvikle-infektioner-eller-andre-sygdomme-forbundet-med-hiv-infektion-du-skal-vre-i-lbende-kontakt-med-din-lge-personer-der-tager-prezista-kan-udvikle-hududslt-i-sjldne-tilflde-kan-hududslttet-blive-alvorligt-eller-mske-livstruende-kontakt-din-lge-hvis-du-fr-hududslt-patienter-der-fr-prezista-sammen-med-raltegravir-mod-hiv-infektion-kan-hyppigere-f-udslt-end-patienter-der-kun-fr-det-ene-af-disse-lgemidler-udslttet-vil-generelt-vre-mildt-eller-moderat-fortl-din-lge-om-dit-helbred-fr-og-under-din-behandling-srg-for-at-tjekke-flgende-punkter-og-fortl-din-lge-hvis-nogen-af-dem-glder-for-dig">hvis
du har alvorlige leverproblemer. Du skal sprge din lge, hvis du ikke
er sikker p, hvor alvorlig din leversygdom er. Det kan vre ndvendigt
at foretage yderligere test. Fortl lgen om alle lgemidler, du tager,
herunder medicin, som du tager gennem munden, inhalerer, indsprjter
eller pfrer p huden. Du m ikke tage PREZISTA sammen med flgende
medicin Hvis du tager et af disse lgemidler, skal du tale med din lge
om at skifte til en anden medicin. 144 Medicin Formlet med medicinen
Avanafil til behandling af impotens Astemizol eller terfenadin til
behandling af symptomer p allergi Triazolam eller midazolam (indtaget
gennem munden) som sovemiddel og/eller til at afhjlpe angst Cisaprid
til behandling af visse mavelidelser Colchicin (hvis du har problemer
med nyrerne og/eller leveren) til behandling af urinsur gigt eller
familir middelhavsfeber Lurasidon, pimozid, quetiapin eller sertindol
til behandling af psykiske lidelser Sekalealkaloider (f.eks. ergotamin,
dihydroergotamin, ergometrin og methylergometrin) til behandling af
migrnehovedpine Amiodaron, bepridil, dronedaron, ivabradin, kinidin,
ranolazin til behandling af visse hjertelidelser som f.eks. unormal
hjerterytme Lovastatin, simvastatin og lomitapid til nedsttelse af
kolesterol i blodet Rifampicin til behandling af visse infektioner ssom
tuberkulose Kombinationsproduktet lopinavir/ritonavir denne medicin mod
hiv tilhrer samme gruppe som PREZISTA Elbasvir/grazoprevir til
behandling af hepatitis C-infektion Alfuzosin til behandling af
forstrret blrehalskirtel (prostata) Sildenafil til behandling af for
hjt blodtryk i lungekredslbet Ticagrelor som hjlp til at hindre
sammenklumpning af blodplader hos patienter, der tidligere har haft et
hjerteanfald Naloxegol til behandling af forstoppelse forrsaget af
opioidbehandling Dapoxetin til behandling af for tidlig sdafgang
Domperidon til behandling af kvalme og opkastning PREZISTA m ikke
kombineres med naturlgemidler, der indeholder perikon (Hypericum
perforatum). Advarsler og forsigtighedsregler Kontakt lgen,
apotekspersonalet eller sygeplejersken, fr du tager PREZISTA. PREZISTA
kan ikke helbrede hiv-infektion. Personer, der tager PREZISTA, kan
stadig udvikle infektioner eller andre sygdomme forbundet med
hiv-infektion. Du skal vre i lbende kontakt med din lge. Personer,
der tager PREZISTA, kan udvikle hududslt. I sjldne tilflde kan
hududslttet blive alvorligt eller mske livstruende. Kontakt din lge,
hvis du fr hududslt. Patienter, der fr PREZISTA sammen med
raltegravir (mod hiv-infektion), kan hyppigere f udslt end patienter,
der kun fr det ene af disse lgemidler. Udslttet vil generelt vre
mildt eller moderat. Fortl din lge om dit helbred FR og UNDER din
behandling Srg for at tjekke flgende punkter og fortl din lge, hvis
nogen af dem glder for dig.</h2>
<h2
id="fortl-din-lge-hvis-du-tidligere-har-haft-problemer-med-leveren-herunder-hepatitis-b--eller-c-infektion-din-lge-kan-vurdere-hvor-alvorlig-din-leversygdom-er-inden-han-eller-hun-beslutter-om-du-kan-tage-prezista">Fortl
din lge, hvis du tidligere har haft problemer med leveren, herunder
hepatitis B- eller C-infektion. Din lge kan vurdere, hvor alvorlig din
leversygdom er, inden han eller hun beslutter, om du kan tage
PREZISTA.</h2>
<h2
id="fortl-din-lge-hvis-du-har-sukkersyge-diabetes-prezista-kan-forhje-blodsukkerniveauet-145">Fortl
din lge, hvis du har sukkersyge (diabetes). PREZISTA kan forhje
blodsukkerniveauet. 145</h2>
<h2
id="fortl-straks-din-lge-hvis-du-bemrker-nogen-symptomer-p-infektion-feks-forstrrede-lymfeknuder-og-feber-hos-nogle-patienter-med-fremskreden-hiv-infektion-som-tidligere-har-haft-infektioner-p-grund-af-svkket-immunforsvar-opportunistisk-infektion-kan-der-forekomme-tegn-og-symptomer-p-betndelsestilstand-fra-tidligere-infektion-kort-tid-efter-pbegyndelse-af-hiv-behandling-det-menes-at-disse-symptomer-skyldes-en-forbedring-af-kroppens-immunforsvar-der-gr-det-muligt-for-kroppen-at-bekmpe-infektioner-der-kan-have-vret-til-stede-uden-nogen-tydelige-symptomer">Fortl
straks din lge, hvis du bemrker nogen symptomer p infektion (f.eks.
forstrrede lymfeknuder og feber). Hos nogle patienter med fremskreden
hiv-infektion som tidligere har haft infektioner p grund af svkket
immunforsvar (opportunistisk infektion) kan der forekomme tegn og
symptomer p betndelsestilstand fra tidligere infektion kort tid efter
pbegyndelse af hiv-behandling. Det menes, at disse symptomer skyldes en
forbedring af kroppens immunforsvar, der gr det muligt for kroppen at
bekmpe infektioner, der kan have vret til stede uden nogen tydelige
symptomer.</h2>
<h2
id="ud-over-de-opportunistiske-infektioner-kan-autoimmune-lidelser-skyldes-at-immunsystemet-angriber-sundt-kropsvv-ogs-opst-efter-du-er-begyndt-at-tage-medicin-til-behandling-af-din-hiv-infektion-autoimmune-lidelser-kan-opst-mange-mneder-efter-du-er-pbegyndt-behandling-du-skal-straks-informere-din-lge-for-at-f-den-ndvendige-behandling-hvis-du-bemrker-symptomer-p-infektion-eller-andre-symptomer-ssom-muskelsvaghed-svaghed-begyndende-i-hnder-og-fdder-og-som-bevger-sig-op-igennem-kroppen-hjertebanken-rysten-eller-hyperaktivitet">Ud
over de opportunistiske infektioner kan autoimmune lidelser (skyldes, at
immunsystemet angriber sundt kropsvv) ogs opst, efter du er begyndt
at tage medicin til behandling af din hiv-infektion. Autoimmune lidelser
kan opst mange mneder efter, du er pbegyndt behandling. Du skal
straks informere din lge for at f den ndvendige behandling, hvis du
bemrker symptomer p infektion eller andre symptomer, ssom
muskelsvaghed, svaghed begyndende i hnder og fdder, og som bevger sig
op igennem kroppen, hjertebanken, rysten eller hyperaktivitet.</h2>
<h2
id="fortl-din-lge-hvis-du-har-en-bldersygdom-hmofili-prezista-kan-ge-risikoen-for-bldning">Fortl
din lge, hvis du har en bldersygdom (hmofili). PREZISTA kan ge
risikoen for bldning.</h2>
<h2
id="fortl-din-lge-hvis-du-er-allergisk-over-for-sulfonamider-anvendes-feks-til-behandling-af-visse-infektioner">Fortl
din lge, hvis du er allergisk over for sulfonamider (anvendes f.eks.
til behandling af visse infektioner).</h2>
<h2
id="fortl-din-lge-hvis-du-har-problemer-med-muskler-eller-knogler-nogle-patienter-der-tager-antiretroviral-kombinationsmedicin-kan-udvikle-en-knoglesygdom-hvor-knoglevvet-dr-p-grund-af-manglende-blodforsyning-til-knoglen-osteonekrose-varigheden-af-antiretroviral-kombinationsbehandling-brug-af-binyrebarkhormoner-alkoholforbrug-alvorlig-svkkelse-af-immunforsvaret-og-hjt-body-mass-index-bmi-kan-vre-nogle-af-de-mange-risikofaktorer-for-udvikling-af-denne-sygdom-tegnene-p-osteonekrose-omfatter-stivhed-mhed-og-smerter-i-led-isr-hofter-kn-og-skuldre-samt-problemer-med-at-bevge-sig-hvis-du-bemrker-nogen-af-disse-symptomer-bedes-du-kontakte-din-lge-ldre-prezista-har-kun-vret-anvendt-til-et-begrnset-antal-patienter-over-65-r-hvis-du-tilhrer-denne-aldersgruppe-skal-du-sprge-din-lge-om-du-kan-anvende-prezista-brn-prezista-er-ikke-beregnet-til-brug-til-brn-under-3-r-eller-med-en-legemsvgt-under-15-kg-brug-af-anden-medicin-sammen-med-prezista-fortl-det-altid-til-lgen-eller-apotekspersonalet-hvis-du-bruger-anden-medicin-for-nylig-har-brugt-anden-medicin-eller-planlgger-at-bruge-anden-medicin-nogle-typer-medicin-m-du-ikke-tage-sammen-med-prezista-disse-er-nvnt-ovenfor-under-overskriften-du-m-ikke-tage-prezista-sammen-med-flgende-medicin-i-de-fleste-tilflde-kan-prezista-tages-sammen-med-hiv-medicin-der-tilhrer-en-anden-gruppe-feks-nrti-nukleosid-revers-transkriptase-hmmere-nnrti-non-nukleosid-revers-transkriptase--hmmere-ccr5-antagonister-og-fi-fusionshmmere-prezista-med-cobicistat-eller-ritonavir-er-ikke-blevet-testet-med-alle-proteasehmmere-og-m-ikke-bruges-med-andre-hiv-proteasehmmere-i-nogle-tilflde-kan-der-vre-behov-for-at-ndre-doseringen-af-andre-lgemidler-du-skal-derfor-altid-fortlle-din-lge-hvis-du-tager-anden-hiv-medicin-og-flge-din-lges-anvisninger-nje-med-hensyn-til-hvilken-medicin-der-kan-tages-sammen-virkningen-af-prezista-kan-blive-nedsat-hvis-du-tager-et-eller-flere-af-flgende-produkter-du-skal-fortlle-din-lge-hvis-du-tager">Fortl
din lge, hvis du har problemer med muskler eller knogler. Nogle
patienter, der tager antiretroviral kombinationsmedicin, kan udvikle en
knoglesygdom, hvor knoglevvet dr p grund af manglende blodforsyning
til knoglen (osteonekrose). Varigheden af antiretroviral
kombinationsbehandling, brug af binyrebarkhormoner, alkoholforbrug,
alvorlig svkkelse af immunforsvaret og hjt Body Mass Index (BMI) kan
vre nogle af de mange risikofaktorer for udvikling af denne sygdom.
Tegnene p osteonekrose omfatter: Stivhed, mhed og smerter i led (isr
hofter, kn og skuldre) samt problemer med at bevge sig. Hvis du
bemrker nogen af disse symptomer, bedes du kontakte din lge. ldre
PREZISTA har kun vret anvendt til et begrnset antal patienter over 65
r. Hvis du tilhrer denne aldersgruppe, skal du sprge din lge, om du
kan anvende PREZISTA. Brn PREZISTA er ikke beregnet til brug til brn
under 3 r eller med en legemsvgt under 15 kg. Brug af anden medicin
sammen med PREZISTA Fortl det altid til lgen eller apotekspersonalet,
hvis du bruger anden medicin, for nylig har brugt anden medicin eller
planlgger at bruge anden medicin. Nogle typer medicin m du ikke tage
sammen med PREZISTA. Disse er nvnt ovenfor under overskriften "Du m
ikke tage PREZISTA sammen med flgende medicin" I de fleste tilflde kan
PREZISTA tages sammen med hiv-medicin, der tilhrer en anden gruppe
f.eks. NRTI (nukleosid revers-transkriptase-hmmere), NNRTI
(non-nukleosid revers-transkriptase- hmmere), CCR5-antagonister og FI
(fusionshmmere). PREZISTA med cobicistat eller ritonavir er ikke blevet
testet med alle proteasehmmere og m ikke bruges med andre
hiv-proteasehmmere. I nogle tilflde kan der vre behov for at ndre
doseringen af andre lgemidler. Du skal derfor altid fortlle din lge,
hvis du tager anden hiv-medicin og flge din lges anvisninger nje med
hensyn til hvilken medicin, der kan tages sammen. Virkningen af PREZISTA
kan blive nedsat, hvis du tager et eller flere af flgende produkter. Du
skal fortlle din lge, hvis du tager:</h2>
<h2
id="phenobarbital-phenytoin-til-forebyggelse-af-krampeanfald">phenobarbital,
phenytoin (til forebyggelse af krampeanfald)</h2>
<h2 id="dexamethason-kortikosteroid">dexamethason (kortikosteroid)</h2>
<h2 id="efavirenz-til-hiv-infektion">efavirenz (til hiv-infektion)</h2>
<h2
id="rifapentin-rifabutin-medicin-til-behandling-af-visse-infektioner-som-feks-tuberkulose">rifapentin,
rifabutin (medicin til behandling af visse infektioner som f.eks.
tuberkulose)</h2>
<h2
id="saquinavir-til-hiv-infektion-146-virkningen-af-anden-medicin-kan-blive-pvirket-hvis-du-tager-prezista-og-din-lge-vil-muligvis-tage-yderligere-blodprver-du-skal-fortlle-din-lge-hvis-du-tager">saquinavir
(til hiv-infektion). 146 Virkningen af anden medicin kan blive pvirket,
hvis du tager PREZISTA, og din lge vil muligvis tage yderligere
blodprver. Du skal fortlle din lge, hvis du tager:</h2>
<h2
id="amlodipin-diltiazem-disopyramid-carvedilol-felodipin-flecainid-lidocain-metoprolol-mexiletin-nifedipin-nicardipin-propafenon-timolol-verapamil-til-hjertesygdomme-da-behandlingsvirkningen-eller-bivirkninger-af-denne-medicin-kan-blive-forstrket">amlodipin,
diltiazem, disopyramid, carvedilol, felodipin, flecainid, lidocain,
metoprolol, mexiletin, nifedipin, nicardipin, propafenon, timolol,
verapamil (til hjertesygdomme), da behandlingsvirkningen eller
bivirkninger af denne medicin kan blive forstrket</h2>
<h2
id="apixaban-dabigatranetexilat-edoxaban-rivaroxaban-warfarin-clopidogrel-til-at-hindre-blodpropper-da-behandlingsvirkningen-eller-bivirkninger-af-denne-medicin-kan-blive-ndret">apixaban,
dabigatranetexilat, edoxaban, rivaroxaban, warfarin, clopidogrel (til at
hindre blodpropper), da behandlingsvirkningen eller bivirkninger af
denne medicin kan blive ndret</h2>
<h2
id="strogenholdig-prvention-og-hormonerstatningsbehandling-prezista-kan-nedstte-virkningen-af-disse-i-forbindelse-med-svangerskabsforebyggelse-anbefales-det-at-du-i-stedet-anvender-prvention-der-ikke-indeholder-hormoner">strogenholdig
prvention og hormonerstatningsbehandling. PREZISTA kan nedstte
virkningen af disse. I forbindelse med svangerskabsforebyggelse
anbefales det, at du i stedet anvender prvention, der ikke indeholder
hormoner</h2>
<h2
id="ethinylestradioldrospirenon-prezista-kan-muligvis-ge-risikoen-for-forhjet-kaliumindhold-i-blodet-pga-drospirenon">ethinylestradiol/drospirenon.
PREZISTA kan muligvis ge risikoen for forhjet kaliumindhold i blodet
pga. drospirenon.</h2>
<h2
id="atorvastatin-pravastatin-rosuvastatin-til-nedsttelse-af-kolesterol-i-blodet-risikoen-for-en-muskelskade-kan-vre-forhjet-din-lge-vil-vurdere-hvilken-kolesterolsnkende-behandling-der-egner-sig-bedst-til-dig">atorvastatin,
pravastatin, rosuvastatin (til nedsttelse af kolesterol i blodet).
Risikoen for en muskelskade kan vre forhjet. Din lge vil vurdere,
hvilken kolesterolsnkende behandling, der egner sig bedst til dig</h2>
<h2 id="clarithromycin-antibiotikum">clarithromycin (antibiotikum)</h2>
<h2
id="ciclosporin-everolimus-tacrolimus-sirolimus-til-dmpning-af-immunforsvaret-da-behandlingsvirkningen-eller-bivirkninger-af-denne-medicin-kan-blive-forstrket">ciclosporin,
everolimus, tacrolimus, sirolimus (til dmpning af immunforsvaret), da
behandlingsvirkningen eller bivirkninger af denne medicin kan blive
forstrket</h2>
<h2
id="kortikosteroider-herunder-betamethason-budesonid-fluticason-mometason-prednison-triamcinolon-disse-lgemidler-anvendes-til-behandling-af-allergier-astma-inflammatoriske-tarmsygdomme-inflammatoriske-tilstande-i-hud-jne-led--og-muskler-samt-andre-inflammatoriske-tilstande-disse-lgemidler-tages-generelt-gennem-munden-inhaleres-injiceres-eller-smres-p-huden-du-m-kun-bruge-disse-lgemidler-hvis-andre-lgemidler-ikke-kan-anvendes-og-kun-efter-en-lgelig-vurdering-og-under-tt-lgelig-overvgning-for-kortikosteroid-bivirkninger">kortikosteroider,
herunder betamethason, budesonid, fluticason, mometason, prednison,
triamcinolon. Disse lgemidler anvendes til behandling af allergier,
astma, inflammatoriske tarmsygdomme, inflammatoriske tilstande i hud,
jne, led- og muskler samt andre inflammatoriske tilstande. Disse
lgemidler tages generelt gennem munden, inhaleres, injiceres eller
smres p huden. Du m kun bruge disse lgemidler, hvis andre lgemidler
ikke kan anvendes, og kun efter en lgelig vurdering og under tt
lgelig overvgning for kortikosteroid-bivirkninger</h2>
<h2
id="buprenorphinnaloxon-medicin-til-behandling-af-afhngighed-af-morfin-og-lignende">buprenorphin/naloxon
(medicin til behandling af afhngighed af morfin og lignende)</h2>
<h2 id="salmeterol-medicin-til-behandling-af-astma">salmeterol (medicin
til behandling af astma)</h2>
<h2
id="artemetherlumefantrin-et-kombinationsprparat-til-behandling-af-malaria">artemether/lumefantrin
(et kombinationsprparat til behandling af malaria)</h2>
<h2
id="dasatinib-everolimus-irinotecan-nilotinib-vinblastin-vincristin-til-behandling-af-krft">dasatinib,
everolimus, irinotecan, nilotinib, vinblastin, vincristin (til
behandling af krft)</h2>
<h2
id="sildenafil-tadalafil-vardenafil-til-behandling-af-impotens-eller-til-behandling-af-en-hjertelungesygdom-kaldet-pulmonal-arteriel-hypertension">sildenafil,
tadalafil, vardenafil (til behandling af impotens eller til behandling
af en hjerte/lungesygdom kaldet pulmonal arteriel hypertension)</h2>
<h2
id="glecaprevirpibrentasvir-til-behandling-af-hepatitis-c-infektion">glecaprevir/pibrentasvir
(til behandling af hepatitis C-infektion)</h2>
<h2 id="fentanyl-oxycodon-tramadol-til-behandling-af-smerter">fentanyl,
oxycodon, tramadol (til behandling af smerter)</h2>
<h2
id="fesoterodin-solifenacin-til-behandling-af-sygdomme-i-urinvejene-din-lge-vil-muligvis-tage-yderligere-blodprver-og-doseringen-af-anden-medicin-skal-muligvis-ndres-da-behandlingsvirkningen-eller-bivirkninger-af-enten-denne-eller-prezista-kan-blive-pvirket-nr-de-kombineres-du-skal-fortlle-det-til-din-lge-hvis-du-tager">fesoterodin,
solifenacin (til behandling af sygdomme i urinvejene). Din lge vil
muligvis tage yderligere blodprver, og doseringen af anden medicin skal
muligvis ndres, da behandlingsvirkningen eller bivirkninger af enten
denne eller PREZISTA kan blive pvirket, nr de kombineres. Du skal
fortlle det til din lge, hvis du tager:</h2>
<h2
id="dabigatranetexilat-edoxaban-warfarin-blodfortyndende-medicin">dabigatranetexilat,
edoxaban, warfarin (blodfortyndende medicin)</h2>
<h2
id="alfentanil-strkt-smertestillende-middel-til-injektion-med-kort-virkningstid-der-anvendes-ved-operationer">alfentanil
(strkt smertestillende middel til injektion med kort virkningstid, der
anvendes ved operationer)</h2>
<h2 id="digoxin-til-behandling-af-visse-hjertesygdomme">digoxin (til
behandling af visse hjertesygdomme)</h2>
<h2 id="clarithromycin-antibiotikum-1">clarithromycin
(antibiotikum)</h2>
<h2
id="itraconazol-isavuconazol-fluconazol-posaconazol-clotrimazol-til-behandling-af-svampeinfektioner-voriconazol-m-kun-tages-efter-en-medicinsk-udredning">itraconazol,
isavuconazol, fluconazol, posaconazol, clotrimazol (til behandling af
svampeinfektioner). Voriconazol m kun tages efter en medicinsk
udredning</h2>
<h2 id="rifabutin-mod-bakterieinfektioner">rifabutin (mod
bakterieinfektioner)</h2>
<h2
id="sildenafil-vardenafil-tadalafil-mod-impotens-eller-for-hjt-blodtryk-i-lungekredslbet">sildenafil,
vardenafil, tadalafil (mod impotens eller for hjt blodtryk i
lungekredslbet)</h2>
<h2
id="amitriptylin-desipramin-imipramin-nortriptylin-paroxetin-sertralin-trazodon-til-behandling-af-depression-og-angst">amitriptylin,
desipramin, imipramin, nortriptylin, paroxetin, sertralin, trazodon (til
behandling af depression og angst)</h2>
<h2 id="maraviroc-til-hiv-infektion">maraviroc (til hiv-infektion)</h2>
<h2 id="methadon-til-behandling-af-opioidafhngighed">methadon (til
behandling af opioidafhngighed)</h2>
<h2
id="carbamazepin-clonazepam-til-forebyggelse-af-krampeanfald-eller-til-behandling-af-visse-typer-nervesmerter">carbamazepin,
clonazepam (til forebyggelse af krampeanfald eller til behandling af
visse typer nervesmerter)</h2>
<h2
id="colchicin-til-behandling-af-urinsur-gigt-eller-familir-middelhavsfeber">colchicin
(til behandling af urinsur gigt eller familir middelhavsfeber)</h2>
<h2
id="bosentan-til-behandling-af-for-hjt-blodtryk-i-lungekredslbet">bosentan
(til behandling af for hjt blodtryk i lungekredslbet)</h2>
<h2
id="buspiron-clorazepat-diazepam-estazolam-flurazepam-midazolam-nr-det-tages-som-injektion-zolpidem-beroligende-midler-147">buspiron,
clorazepat, diazepam, estazolam, flurazepam, midazolam, nr det tages
som injektion, zolpidem (beroligende midler) 147</h2>
<h2
id="perphenazin-risperidon-thioridazin-til-behandling-af-psykiske-lidelser">perphenazin,
risperidon, thioridazin (til behandling af psykiske lidelser)</h2>
<p>metformin (til behandling af type 2-diabetes). Dette er ikke en
komplet liste over lgemidler. Fortl din lge om al medicin, du tager.
Brug af PREZISTA sammen med mad og drikke Se punkt 3 "Sdan skal du tage
PREZISTA". Graviditet og amning Fortl straks din lge, hvis du er
gravid eller planlgger at blive gravid. Gravide kvinder br ikke tage
PREZISTA sammen med ritonavir, medmindre lgen specifikt har foreskrevet
det. Gravide kvinder br ikke tage PREZISTA sammen med cobicistat. P
grund af risikoen for bivirkninger hos det ammede barn m kvinder ikke
amme, hvis de fr PREZISTA. Amning frardes hos kvinder, der er
hiv-positive, da hiv-infektion kan overfres til barnet gennem
modermlken. Hvis du ammer eller ptnker at amme, br du drfte det med
lgen hurtigst muligt. Trafik- og arbejdssikkerhed Du m ikke betjene
maskiner eller kre bil, hvis du fler dig svimmel efter indtagelse af
PREZISTA. PREZISTA oral suspension indeholder
natriummethylparahydroxybenzoat Dette indholdsstof kan give allergiske
reaktioner (kan optrde efter behandlingen). PREZISTA indeholder natrium
Dette lgemiddel indeholder mindre end 1 mmol natrium (23 mg) pr. ml,
dvs. det er i det vsentlige natriumfrit.</p>
 </div>"""   
                    
* section[=].section[+]
  * title =  "3. Sdan skal du tage prezista"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. Sdan skal du tage prezista"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2
id="tag-altid-lgemidlet-njagtigt-som-beskrevet-i-denne-indlgsseddel-eller-efter-lgens-apotekspersonalets-eller-sygeplejerskens-anvisning-er-du-i-tvivl-s-sprg-lgen-apotekspersonalet-eller-sygeplejersken-selvom-du-fr-det-bedre-m-du-ikke-stoppe-med-at-tage-prezista-og-cobicistat-eller-ritonavir-uden-frst-at-tale-med-din-lge-efter-behandlingen-er-pbegyndt-m-du-ikke-ndre-dosis-eller-lgemiddelform-eller-afbryde-behandlingen-uden-frst-at-tale-med-lgen-dosis-til-brn-fra-3-r-og-opefter-med-en-legemsvgt-p-mindst-15-kg-som-ikke-tidligere-har-fet-medicin-mod-hiv-infektion-barnets-lge-vil-afgre-dette-lgen-vil-beregne-den-korrekte-daglige-dosis-p-grundlag-af-barnets-vgt-og-alder-se-tabellen-nedenfor-dosis-m-ikke-overstige-den-anbefalede-dosis-til-voksne-som-er-800-mg-prezista-sammen-med-150-mg-cobicistat-eller-100-mg-ritonavir-en-gang-dagligt-lgen-vil-fortlle-dig-hvor-meget-prezista-oral-suspension-og-hvor-meget-cobicistat-tablet-eller-ritonavir-kapsler-tabletter-eller-oplsning-barnet-skal-tage-legemsvgt-en-dosis-prezista-er-en-dosis-ritonavira-er-en-dosis-cobicistat-er-mellem-15-og-30-kg-600-mg-6-ml-100-mg-12-ml-tag-ikke-mellem-30-og-40-kg-675-mg-68-ml-100-mg-12-ml-tag-ikke-mere-end-40-kg-800-mg-8-ml-100-mg-12-ml-150-mgb-a-ritonavir-oral-oplsning-80-mgml-b-barnet-skal-vre-12-r-eller-ldre-barnet-skal-tage-prezista-hver-dag-og-altid-sammen-med-150-mg-cobicistat-eller-100-mg-ritonavir-og-sammen-med-mad-prezista-virker-ikke-korrekt-uden-cobicistat-eller-ritonavir-og-mad-barnet-148-skal-indtage-et-mltid-eller-et-mellemmltid-inden-for-30-minutter-fr-det-tager-prezista-og-enten-cobicistat-eller-ritonavir-typen-af-mad-er-ikke-vigtig-barnets-lge-vil-afgre-om-barnet-skal-tage-prezista-sammen-med-enten-cobicistat-eller-ritonavir-dosis-til-brn-fra-3-r-og-opefter-med-en-legemsvgt-p-mindst-15-kg-som-tidligere-har-fet-medicin-mod-hiv-infektion-barnets-lge-vil-afgre-dette-lgen-vil-beregne-den-korrekte-dosis-p-grundlag-af-barnets-vgt-og-alder-se-tabellen-nedenfor-lgen-vil-afgre-om-en-dosis-en-gang-dagligt-eller-to-gange-dagligt-er-passende-for-barnet-dosis-m-ikke-overstige-den-anbefalede-dosis-til-voksne-der-er-600-mg-prezista-sammen-med-150-mg-cobicistat-eller-100-mg-ritonavir-2-gange-dagligt-eller-800-mg-prezista-sammen-med-100-mg-ritonavir-en-gang-dagligt-lgen-vil-fortlle-dig-hvor-meget-prezista-oral-suspension-og-hvor-meget-cobicistat-tablet-eller-ritonavir-kapsler-tabletter-eller-oral-oplsning-barnet-skal-have-dosering-to-gange-dagligt-legemsvgt-en-dosis-prezista-er-en-dosis-ritonavira-er-mellem-15-og-30-kg-380-mg-38-ml-50-mg-06-ml-mellem-30-og-40-kg-460-mg-46-ml-60-mg-08-ml-mere-end-40-kg-600-mg-6-ml-100-mg-12-ml-a-ritonavir-oral-oplsning-80-mgml-dosering-en-gang-dagligt-legemsvgt-en-dosis-prezista-er-en-dosis-ritonavira-er-en-dosis-cobicistat-er-mellem-15-og-30-kg-600-mg-6-ml-100-mg-12-ml-tag-ikke-mellem-30-og-40-kg-675-mg-68-ml-100-mg-12-ml-tag-ikke-mere-end-40-kg-800-mg-8-ml-100-mg-12-ml-150-mgb-a-ritonavir-oral-oplsning-80-mgml-b-barnet-skal-vre-12-r-eller-ldre-anvisninger-for-brn">Tag
altid lgemidlet njagtigt som beskrevet i denne indlgsseddel eller
efter lgens, apotekspersonalets eller sygeplejerskens anvisning. Er du
i tvivl, s sprg lgen, apotekspersonalet eller sygeplejersken. Selvom
du fr det bedre, m du ikke stoppe med at tage PREZISTA og cobicistat
eller ritonavir uden frst at tale med din lge. Efter behandlingen er
pbegyndt, m du ikke ndre dosis eller lgemiddelform eller afbryde
behandlingen uden frst at tale med lgen. Dosis til brn fra 3 r og
opefter med en legemsvgt p mindst 15 kg, som ikke tidligere har fet
medicin mod hiv-infektion (barnets lge vil afgre dette) Lgen vil
beregne den korrekte daglige dosis p grundlag af barnets vgt og alder
(se tabellen nedenfor). Dosis m ikke overstige den anbefalede dosis til
voksne, som er 800 mg PREZISTA sammen med 150 mg cobicistat eller 100 mg
ritonavir en gang dagligt. Lgen vil fortlle dig, hvor meget PREZISTA
oral suspension og hvor meget cobicistat (tablet) eller ritonavir
(kapsler, tabletter eller oplsning) barnet skal tage. Legemsvgt En
dosis PREZISTA er En dosis ritonavira er En dosis cobicistat er mellem
15 og 30 kg 600 mg (6 ml) 100 mg (1,2 ml) Tag ikke mellem 30 og 40 kg
675 mg (6,8 ml) 100 mg (1,2 ml) Tag ikke mere end 40 kg 800 mg (8 ml)
100 mg (1,2 ml) 150 mgb a ritonavir oral oplsning: 80 mg/ml b barnet
skal vre 12 r eller ldre Barnet skal tage PREZISTA hver dag og altid
sammen med 150 mg cobicistat eller 100 mg ritonavir og sammen med mad.
PREZISTA virker ikke korrekt uden cobicistat eller ritonavir og mad.
Barnet 148 skal indtage et mltid eller et mellemmltid inden for 30
minutter, fr det tager PREZISTA og enten cobicistat eller ritonavir.
Typen af mad er ikke vigtig. Barnets lge vil afgre, om barnet skal
tage PREZISTA sammen med enten cobicistat eller ritonavir. Dosis til
brn fra 3 r og opefter med en legemsvgt p mindst 15 kg, som
tidligere har fet medicin mod hiv-infektion (barnets lge vil afgre
dette) Lgen vil beregne den korrekte dosis p grundlag af barnets vgt
og alder (se tabellen nedenfor). Lgen vil afgre, om en dosis en gang
dagligt eller to gange dagligt er passende for barnet. Dosis m ikke
overstige den anbefalede dosis til voksne, der er 600 mg PREZISTA sammen
med 150 mg cobicistat eller 100 mg ritonavir 2 gange dagligt eller 800
mg PREZISTA sammen med 100 mg ritonavir en gang dagligt. Lgen vil
fortlle dig, hvor meget PREZISTA oral suspension og hvor meget
cobicistat (tablet) eller ritonavir (kapsler, tabletter eller oral
oplsning) barnet skal have. Dosering to gange dagligt Legemsvgt En
dosis PREZISTA er En dosis ritonavira er mellem 15 og 30 kg 380 mg (3,8
ml) 50 mg (0,6 ml) mellem 30 og 40 kg 460 mg (4,6 ml) 60 mg (0,8 ml)
mere end 40 kg 600 mg (6 ml) 100 mg (1,2 ml) a ritonavir oral oplsning:
80 mg/ml Dosering en gang dagligt Legemsvgt En dosis PREZISTA er En
dosis ritonavira er En dosis cobicistat er mellem 15 og 30 kg 600 mg (6
ml) 100 mg (1,2 ml) Tag ikke mellem 30 og 40 kg 675 mg (6,8 ml) 100 mg
(1,2 ml) Tag ikke mere end 40 kg 800 mg (8 ml) 100 mg (1,2 ml) 150 mgb a
ritonavir oral oplsning: 80 mg/ml b barnet skal vre 12 r eller ldre
Anvisninger for brn</h2>
<h2
id="barnet-skal-altid-tage-prezista-sammen-med-cobicistat-eller-ritonavir-prezista-virker-ikke-korrekt-uden-cobicistat-eller-ritonavir">Barnet
skal altid tage PREZISTA sammen med cobicistat eller ritonavir. PREZISTA
virker ikke korrekt uden cobicistat eller ritonavir.</h2>
<h2
id="barnet-skal-tage-den-beregnede-dosis-af-prezista-og-ritonavir-2-gange-dagligt-eller-1-gang-dagligt-eller-prezista-og-cobicistat-1-gang-dagligt-hvis-barnet-skal-have-prezista-2-gange-dagligt-skal-det-tage-en-dosis-om-morgenen-og-en-dosis-om-aftenen-barnets-lge-faststter-den-rette-behandling-til-dit-barn">Barnet
skal tage den beregnede dosis af PREZISTA og ritonavir 2 gange dagligt
eller 1 gang dagligt eller PREZISTA og cobicistat 1 gang dagligt. Hvis
barnet skal have PREZISTA 2 gange dagligt, skal det tage en dosis om
morgenen og en dosis om aftenen. Barnets lge faststter den rette
behandling til dit barn.</h2>
<h2
id="barnet-skal-tage-prezista-sammen-med-mad-prezista-virker-ikke-korrekt-uden-mad-typen-af-mad-er-ikke-vigtig-dosis-til-voksne-som-ikke-tidligere-har-fet-hiv-medicin-din-lge-vil-afgre-dette-den-sdvanlige-dosis-prezista-er-800-mg-en-gang-dagligt-du-skal-tage-prezista-hver-dag-og-altid-sammen-med-150-mg-cobicistat-eller-100-mg-ritonavir-og-sammen-med-mad-prezista-virker-ikke-korrekt-uden-cobicistat-eller-ritonavir-og-mad-du-skal-indtage-et-mltid-eller-mellemmltid-inden-for-30-minutter-fr-du-tager-prezista-og-cobicistat-eller-ritonavir-typen-af-mad-er-ikke-vigtig-hold-ikke-op-med-at-tage-prezista-og-cobicistat-eller-ritonavir-uden-frst-at-tale-med-din-lge-selv-om-du-fr-det-bedre-dosis-til-voksne-som-tidligere-har-fet-hiv-medicin-din-lge-vil-afgre-dette-dosis-er-enten">Barnet
skal tage PREZISTA sammen med mad. PREZISTA virker ikke korrekt uden
mad. Typen af mad er ikke vigtig. Dosis til voksne, som ikke tidligere
har fet hiv-medicin (din lge vil afgre dette) Den sdvanlige dosis
PREZISTA er 800 mg en gang dagligt. Du skal tage PREZISTA hver dag og
altid sammen med 150 mg cobicistat eller 100 mg ritonavir og sammen med
mad. PREZISTA virker ikke korrekt uden cobicistat eller ritonavir og
mad. Du skal indtage et mltid eller mellemmltid inden for 30 minutter,
fr du tager PREZISTA og cobicistat eller ritonavir. Typen af mad er
ikke vigtig. Hold ikke op med at tage PREZISTA og cobicistat eller
ritonavir uden frst at tale med din lge, selv om du fr det bedre.
Dosis til voksne, som tidligere har fet hiv-medicin (din lge vil
afgre dette) Dosis er enten:</h2>
<h2
id="600-mg-prezista-sammen-med-100-mg-ritonavir-to-gange-dagligt-eller">600
mg PREZISTA sammen med 100 mg ritonavir to gange dagligt. ELLER</h2>
<h2
id="800-mg-prezista-sammen-med-150-mg-cobicistat-eller-100-mg-ritonavir-en-gang-dagligt-tal-med-din-lge-om-hvilken-dosis-der-er-den-rette-til-dig-149-anvisninger-for-voksne">800
mg PREZISTA sammen med 150 mg cobicistat eller 100 mg ritonavir en gang
dagligt. Tal med din lge om, hvilken dosis der er den rette til dig.
149 Anvisninger for voksne</h2>
<h2
id="tag-altid-prezista-sammen-med-cobicistat-eller-ritonavir-prezista-virker-ikke-korrekt-uden-cobicistat-eller-ritonavir">Tag
altid PREZISTA sammen med cobicistat eller ritonavir. PREZISTA virker
ikke korrekt uden cobicistat eller ritonavir.</h2>
<p>Tag PREZISTA sammen med mad. PREZISTA virker ikke korrekt uden mad.
Typen af mad er ikke vigtig. Brugsanvisning Brug doseringssprjten, der
flger med pakningen, til at afmle dosis njagtigt:</p>
<ol type="1">
<li>Ryst flasken godt hver gang, du skal bruge den.</li>
<li>bn flasken med PREZISTA oral suspension ved at trykke lget ned og
dreje det mod uret.</li>
<li>Tryk den vedlagte doseringssprjte helt ned i flasken.</li>
<li>Trk stemplet ud, indtil stempelpladen er ud for den streg, der
svarer til den dosis, din lge har foreskrevet.</li>
<li>Udtag din dosis PREZISTA. Anbring spidsen af doseringssprjten i
munden. Tryk sprjtens stempel og synk dosen.</li>
<li>St lget p flasken efter brug og opbevar PREZISTA oral suspension
som anvist under punkt 5 nedenfor.</li>
<li>Fjern stemplet fra selve sprjten og skyl begge dele med vand. Lad
det lufttrre efter brug.</li>
<li>Efter lufttrring skal doseringssprjten samles igen og opbevares
sammen med flasken med PREZISTA. Doseringssprjten m ikke anvendes til
andre lgemidler. Hvis du har taget for meget PREZISTA Kontakt straks
din lge, apotekspersonalet eller sygeplejersken. Hvis du har glemt at
tage PREZISTA Hvis du tager PREZISTA to gange dagligt, og du kommer i
tanke om den glemte dosis inden for 6 timer, skal du straks tage en
dosis. Du skal altid tage PREZISTA med ritonavir og mad. Hvis du kommer
i tanke om det efter mere end 6 timer, skal du springe den pgldende
dosis over og tage de nste doser som sdvanligt. Du m ikke tage en
dobbeltdosis som erstatning for den glemte dosis. Hvis du tager PREZISTA
n gang dagligt, og du kommer i tanke om den glemte dosis inden for 12
timer, skal du straks tage en dosis. Du skal altid tage PREZISTA med
cobicistat eller ritonavir og mad. Hvis du kommer i tanke om det efter
mere end 12 timer, skal du springe den pgldende dosis over og tage de
nste doser som sdvanligt. Du m ikke tage en dobbeltdosis som
erstatning for den glemte dosis. Hvis du kaster op efter at have taget
PREZISTA og cobicistat eller ritonavir Hvis du kaster op inden for 4
timer efter at have taget medicinen, skal du tage en ny dosis PREZISTA
og cobicistat eller ritonavir sammen med mad snarest muligt. Hvis du
kaster op mere end 4 timer efter at have taget medicinen, behver du
ikke at tage en ny dosis PREZISTA og cobicistat eller ritonavir, fr det
er tid til den nste planlagte dosis. Kontakt din lge, hvis du er i
tvivl om, hvad du skal gre, hvis du har glemt at tage en dosis eller
har kastet op. 150 Du m ikke stoppe med at tage PREZISTA uden frst at
tale med din lge Lgemidler til behandling af hiv kan f dig til at
fle dig bedre. Selvom du har det bedre, m du ikke stoppe med at tage
PREZISTA. Tal med din lge frst. Sprg lgen, apotekspersonalet eller
sygeplejersken, hvis der er noget, du er i tvivl om.</li>
</ol>
 </div>"""         

        
* section[=].section[+]
  * title = "4. Bivirkninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Bivirkninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2
id="under-hiv-behandling-kan-der-forekomme-vgtstigning-samt-forhjede-niveauer-af-lipider-og-glukose-i-blodet-dette-er-til-dels-forbundet-med-forbedret-helbredstilstand-og-med-livsstil-og-for-lipidernes-vedkommende-sommetider-med-selve-hiv-medicinen-lgen-vil-holde-je-med-disse-ndringer-dette-lgemiddel-kan-som-alle-andre-lgemidler-give-bivirkninger-men-ikke-alle-fr-bivirkninger-fortl-din-lge-hvis-du-fr-nogen-af-de-flgende-bivirkninger-der-er-rapporteret-om-leverproblemer-der-somme-tider-kan-vre-alvorlige-din-lge-br-udfre-nogle-blodprver-fr-du-starter-p-prezista-hvis-du-har-kronisk-hepatitis-b-eller-c-skal-du-oftere-til-blodprvekontrol-hos-lgen-fordi-du-s-har-en-get-risiko-for-at-f-leverproblemer-tal-med-din-lge-om-symptomerne-p-leverproblemer-de-kan-omfatte-gulfarvning-af-huden-og-det-hvide-i-jene-mrk-tefarvet-urin-bleg-affring-kvalme-opkastning-appetittab-eller-smerter-jag-eller-smerter-og-ubehag-i-hjre-side-under-ribbenene-hududslt-ses-oftere-ved-kombination-af-raltegravir-kle-udslttet-er-sndvanligvis-mildt-til-moderat-et-hududslt-kan-ogs-vre-et-symptom-p-en-sjlden-men-alvorlig-situation-det-er-vigtigt-at-tale-med-lgen-hvis-du-fr-udslt-din-lge-vil-rdgive-dig-om-hvad-du-skal-gre-ved-symptomerne-eller-om-du-skal-holde-op-med-at-tage-prezista-andre-alvorlige-bivirkninger-var-diabetes-almindelig-og-betndelse-i-bugspytkirtlen-ikke-almindelig-meget-almindelige-bivirkninger-kan-forekomme-hos-flere-end-1-ud-af-10-personer">Under
hiv-behandling kan der forekomme vgtstigning samt forhjede niveauer af
lipider og glukose i blodet. Dette er til dels forbundet med forbedret
helbredstilstand og med livsstil, og for lipidernes vedkommende
sommetider med selve hiv-medicinen. Lgen vil holde je med disse
ndringer. Dette lgemiddel kan som alle andre lgemidler give
bivirkninger, men ikke alle fr bivirkninger. Fortl din lge, hvis du
fr nogen af de flgende bivirkninger Der er rapporteret om
leverproblemer, der somme tider kan vre alvorlige. Din lge br udfre
nogle blodprver, fr du starter p PREZISTA. Hvis du har kronisk
hepatitis B eller C, skal du oftere til blodprvekontrol hos lgen,
fordi du s har en get risiko for at f leverproblemer. Tal med din
lge om symptomerne p leverproblemer. De kan omfatte gulfarvning af
huden og det hvide i jene, mrk (tefarvet) urin, bleg affring, kvalme,
opkastning, appetittab eller smerter, jag eller smerter og ubehag i
hjre side under ribbenene. Hududslt (ses oftere ved kombination af
raltegravir), kle. Udslttet er sndvanligvis mildt til moderat. Et
hududslt kan ogs vre et symptom p en sjlden, men alvorlig
situation. Det er vigtigt at tale med lgen, hvis du fr udslt. Din
lge vil rdgive dig om, hvad du skal gre ved symptomerne, eller om du
skal holde op med at tage PREZISTA. Andre alvorlige bivirkninger var
diabetes (almindelig) og betndelse i bugspytkirtlen (ikke almindelig).
Meget almindelige bivirkninger (kan forekomme hos flere end 1 ud af 10
personer)</h2>
<h2
id="diarr-almindelige-bivirkninger-kan-forekomme-hos-op-til-1-ud-af-10-personer">diarr
Almindelige bivirkninger (kan forekomme hos op til 1 ud af 10
personer)</h2>
<h2
id="opkastning-kvalme-mavesmerter-eller--udspiling-fordjelsesbesvr-luft-i-tarmene">opkastning,
kvalme, mavesmerter eller -udspiling, fordjelsesbesvr, luft i
tarmene</h2>
<h2
id="hovedpine-trthed-svimmelhed-dsighed-flelseslshed-prikken-eller-smerter-i-hnder-eller-fdder-svkkelse-af-styrke-besvr-med-at-falde-i-svn-ikke-almindelige-bivirkninger-kan-forekomme-hos-op-til-1-ud-af-100-personer">hovedpine,
trthed, svimmelhed, dsighed, flelseslshed, prikken eller smerter i
hnder eller fdder, svkkelse af styrke, besvr med at falde i svn
Ikke almindelige bivirkninger (kan forekomme hos op til 1 ud af 100
personer)</h2>
<h2
id="brystsmerter-ndringer-i-elektrokardiogram-hurtig-puls">brystsmerter,
ndringer i elektrokardiogram, hurtig puls</h2>
<h2
id="nedsat-eller-unormal-hudflsomhed-prikkende-fornemmelse-opmrksomhedsforstyrrelser-hukommelsestab-balanceproblemer">nedsat
eller unormal hudflsomhed, prikkende fornemmelse,
opmrksomhedsforstyrrelser, hukommelsestab, balanceproblemer</h2>
<h2 id="ndedrtsbesvr-hoste-nseblod-halsirritation">ndedrtsbesvr,
hoste, nseblod, halsirritation</h2>
<h2
id="betndelse-i-mave-eller-mund-halsbrand-opkastningsfornemmelser-tr-mund-ubehag-i-maven-forstoppelse-rben">betndelse
i mave eller mund, halsbrand, opkastningsfornemmelser, tr mund, ubehag
i maven, forstoppelse, rben</h2>
<h2
id="nyresvigt-nyresten-besvr-med-vandladning-hyppig-eller-overdreven-vandladning-til-tider-om-natten">nyresvigt,
nyresten, besvr med vandladning, hyppig eller overdreven vandladning
til tider om natten</h2>
<h2
id="nldefeber-alvorlige-hvelser-i-huden-eller-andre-vv-hyppigst-lber-eller-jne-eksem-meget-kraftig-svedafsondring-nattesved-hrtab-akne-skllet-hud-misfarvning-af-negle">nldefeber,
alvorlige hvelser i huden eller andre vv (hyppigst lber eller jne),
eksem, meget kraftig svedafsondring, nattesved, hrtab, akne, skllet
hud, misfarvning af negle</h2>
<h2
id="muskelsmerter-muskelkramper-eller--svaghed-smerter-i-lemmerne-knogleskrhed">muskelsmerter,
muskelkramper eller -svaghed, smerter i lemmerne, knogleskrhed</h2>
<h2
id="nedsttelse-af-skjoldbruskkirtlens-funktion-dette-kan-ses-ved-en-blodprve">nedsttelse
af skjoldbruskkirtlens funktion. Dette kan ses ved en blodprve.</h2>
<h2 id="forhjet-blodtryk-rdme">forhjet blodtryk, rdme</h2>
<h2 id="rde-eller-trre-jne">rde eller trre jne</h2>
<h2
id="feber-hvede-ben-p-grund-af-vske-utilpashed-irritabilitet-smerte">feber,
hvede ben p grund af vske, utilpashed, irritabilitet, smerte</h2>
<h2 id="symptomer-p-infektion-herpes-simplex">symptomer p infektion,
herpes simplex</h2>
<h2 id="impotens-strre-bryster-151">impotens, strre bryster 151</h2>
<h2
id="svnproblemer-svnighed-depression-angst-unormale-drmme-nedgang-i-seksuallyst-sjldne-bivirkninger-kan-forekomme-hos-op-til-1-ud-af-1-000-personer">svnproblemer,
svnighed, depression, angst, unormale drmme, nedgang i seksuallyst.
Sjldne bivirkninger (kan forekomme hos op til 1 ud af 1 000
personer)</h2>
<h2
id="en-reaktion-kaldet-dress-et-alvorligt-udslt-der-kan-vre-ledsaget-af-feber-trthed-hvelser-i-ansigt-eller-lymfekirtler-gning-i-antallet-af-eosinofile-celler-en-type-hvide-blodlegemer-pvirkning-af-lever-nyrer-eller-lunger">en
reaktion kaldet DRESS [et alvorligt udslt, der kan vre ledsaget af
feber, trthed, hvelser i ansigt eller lymfekirtler, gning i antallet
af eosinofile celler (en type hvide blodlegemer), pvirkning af lever,
nyrer eller lunger]</h2>
<h2 id="hjerteanfald-langsom-puls-hjertebanken">hjerteanfald, langsom
puls, hjertebanken</h2>
<h2 id="synsforstyrrelser">synsforstyrrelser</h2>
<h2 id="kulderystelser-unormal-flelse">kulderystelser, unormal
flelse</h2>
<h2
id="flelse-af-forvirring-eller-desorientering-humrndring-rastlshed">flelse
af forvirring eller desorientering, humrndring, rastlshed</h2>
<h2
id="besvimelse-epileptiske-anfald-ndring-i-eller-tab-af-smagsoplevelse">besvimelse,
epileptiske anfald, ndring i eller tab af smagsoplevelse</h2>
<h2
id="mundsr-opkastning-af-blod-betndelse-i-lberne-trre-lber-belagt-tunge">mundsr,
opkastning af blod, betndelse i lberne, trre lber, belagt tunge</h2>
<h2 id="snue">snue</h2>
<h2 id="beskadigelse-af-huden-tr-hud">beskadigelse af huden, tr
hud</h2>
<h2
id="stive-muskler-eller-led-ledsmerter-med-eller-uden-betndelse">stive
muskler eller led, ledsmerter med eller uden betndelse</h2>
<h2
id="ndringer-i-visse-blodlegemer-eller-i-blodets-kemiske-sammenstning-de-fremgr-af-blod--eller-urinprver-lgen-vil-forklare-dette-for-dig-eksempel-stigning-i-antallet-af-visse-hvide-blodlegemer">ndringer
i visse blodlegemer eller i blodets kemiske sammenstning. De fremgr af
blod- eller urinprver. Lgen vil forklare dette for dig. Eksempel:
stigning i antallet af visse hvide blodlegemer</h2>
<h2
id="darunavir-krystaller-i-nyrerne-som-forrsager-nyresygdom-nogle-bivirkninger-er-typiske-for-hiv-medicin-i-samme-gruppe-som-prezista-disse-omfatter">darunavir-krystaller
i nyrerne, som forrsager nyresygdom. Nogle bivirkninger er typiske for
hiv-medicin i samme gruppe som PREZISTA. Disse omfatter:</h2>
<p>muskelsmerter, -mhed eller svaghed. Disse muskellidelser har i
sjldne tilflde vret alvorlige. Indberetning af bivirkninger Hvis du
oplever bivirkninger, br du tale med din lge, apotekspersonalet eller
sygeplejersken. Dette glder ogs mulige bivirkninger, som ikke er
medtaget i denne indlgsseddel. Du eller dine prrende kan ogs
indberette bivirkninger direkte til Lgemiddelstyrelsen via det
nationale rapporteringssystem anfrt i Appendiks V. Ved at indrapportere
bivirkninger kan du hjlpe med at fremskaffe mere information om
sikkerheden af dette lgemiddel.</p>
 </div>"""      
        
* section[=].section[+]
  * title = "5. Opbevaring"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. Opbevaring"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lgemidlet utilgngeligt for brn. Brug ikke lgemidlet efter
den udlbsdato, der str p sken og flasken efter EXP. Udlbsdatoen er
den sidste dag i den nvnte mned. M ikke opbevares ved temperaturer
over 30 C. M ikke opbevares i kleskab eller nedfryses. M ikke
udsttes for hje temperaturer. Opbevares i den originale beholder.
Sprg apotekspersonalet, hvordan du skal bortskaffe medicinrester. Af
hensyn til miljet m du ikke smide medicinrester i aflbet, toilettet
eller skraldespanden.</p>
 </div>"""      
        
        
* section[=].section[+]
  * title = "6. Pakningsstrrelser og yderligere oplysninger"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Pakningsstrrelser og yderligere oplysninger"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2 id="prezista-indeholder">PREZISTA indeholder:</h2>
<h2
id="aktivt-stof-darunavir-hver-ml-indeholder-100-mg-darunavir-som-ethanolat">Aktivt
stof: darunavir. Hver ml indeholder 100 mg darunavir (som
ethanolat).</h2>
<h2
id="vrige-indholdsstoffer-hydroxypropylcellulose-mikrokrystallinsk-cellulose-og-carmellosenatrium-citronsyremonohydrat-sucralose-jordbr-med-flde-aroma-aroma-til-smagskorrektion-natriummethylparahydroxybenzoat-e219-saltsyre-til-justering-af-ph-renset-vand-152-udseende-og-pakningsstrrelser-hvid-til-offwhite-opaliserende-oral-suspension-udleveres-i-en-200-ml-ravfarvet-glasflaske-med-brnesikret-prop-af-polypropylen-og-vedlagt-en-6-ml-doseringssprjte-af-lavdensitetspolyethylen-ldpe-med-mlestreger-for-hver-02-ml-flaskehalsen-udfyldes-af-en-ldpe-indsats-til-placering-af-doseringssprjten-doseringssprjten-m-ikke-anvendes-til-andre-lgemidler-prezista-fs-ogs-som-75-mg-150-mg-400-mg-600-mg-og-800-mg-filmovertrukne-tabletter-indehaver-af-markedsfringstilladelsen-janssen-cilag-international-nv-turnhoutseweg-30-b-2340-beerse-belgien-fremstiller-janssen-pharmaceutica-nv-turnhoutseweg-30-b-2340-beerse-belgien-hvis-du-nsker-yderligere-oplysninger-om-dette-lgemiddel-skal-du-henvende-dig-til-den-lokale-reprsentant-for-indehaveren-af-markedsfringstilladelsen-belgibelgiquebelgien-janssen-cilag-nv-teltl-32-14-64-94-11-janssenjacbejnjcom-lietuva-uab-johnson--johnson-tel-370-5-278-68-88-ltitsjnjcom--------359-2-489-94-00-jjsafetyitsjnjcom-luxembourgluxemburg-janssen-cilag-nv-tltel-32-14-64-94-11-janssenjacbejnjcom-esk-republika-janssen-cilag-sro-tel-420-227-012-227-magyarorszg-janssen-cilag-kft-tel-36-1-884-2858-janssenhuitsjnjcom-danmark-janssen-cilag-as-tlf-45-4594-8282-jacdkitsjnjcom-malta-am-mangion-ltd-tel-356-2397-6000-deutschland-janssen-cilag-gmbh-tel-49-2137-955-955-jancilitsjnjcom-nederland-janssen-cilag-bv-tel-31-76-711-1111-janssenjacnljnjcom-eesti-uab-johnson--johnson-eesti-filiaal-tel-372-617-7410-eeitsjnjcom-norge-janssen-cilag-as-tlf-47-24-12-65-00-jacnoitsjnjcom--janssen-cilag---t-30-210-80-90-000-sterreich-janssen-cilag-pharma-gmbh-tel-43-1-610-300-espaa-janssen-cilag-sa-tel-34-91-722-81-00-contactoitsjnjcom-polska-janssen-cilag-polska-sp-z-oo-tel-48-22-237-60-00-153-france-janssen-cilag-tl-0-800-25-50-75--33-1-55-00-40-03-medisourceitsjnjcom-portugal-janssen-cilag-farmacutica-lda-tel-351-214-368-600-hrvatska-johnson--johnson-se-doo-tel-385-1-6610-700-jjsafetyjnjcrjnjcom-romnia-johnson--johnson-romnia-srl-tel-40-21-207-1800-ireland-janssen-sciences-ireland-uc-tel-353-1-800-709-122-slovenija-johnson--johnson-doo-tel-386-1-401-18-00-janssen_safety_sloitsjnjcom-sland-janssen-cilag-ab-co-vistor-hf-smi-354-535-7000-janssenvistoris-slovensk-republika-johnson--johnson-sro-tel-421-232-408-400-italia-janssen-cilag-spa-tel-800688777--39-02-2510-1-janssenitaitsjnjcom-suomifinland-janssen-cilag-oy-puhtel-358-207-531-300-jacfiitsjnjcom------357-22-207-700-sverige-janssen-cilag-ab-tfn-46-8-626-50-00-jacseitsjnjcom-latvija-uab-johnson--johnson-filile-latvij-tel-371-678-93561-lvitsjnjcom-united-kingdom-northern-ireland-janssen-sciences-ireland-uc-tel-44-1-494-567-444-denne-indlgsseddel-blev-senest-ndret-mm-du-kan-finde-yderligere-oplysninger-om-dette-lgemiddel-p-det-europiske-lgemiddelagenturs-hjemmeside-httpwwwemaeuropaeu-154-indlgsseddel-information-til-brugeren-prezista-75-mg-filmovertrukne-tabletter-darunavir-ls-denne-indlgsseddel-grundigt-inden-du-begynder-at-tage-dette-lgemiddel-da-den-indeholder-vigtige-oplysninger">vrige
indholdsstoffer: Hydroxypropylcellulose, mikrokrystallinsk cellulose og
carmellosenatrium, citronsyremonohydrat, sucralose, "jordbr med flde"
aroma, aroma til smagskorrektion, natriummethylparahydroxybenzoat
(E219), saltsyre (til justering af pH), renset vand. 152 Udseende og
pakningsstrrelser Hvid til offwhite opaliserende oral suspension.
Udleveres i en 200 ml ravfarvet glasflaske med brnesikret prop af
polypropylen og vedlagt en 6 ml doseringssprjte af
lavdensitetspolyethylen (LDPE) med mlestreger for hver 0,2 ml.
Flaskehalsen udfyldes af en LDPE-indsats til placering af
doseringssprjten. Doseringssprjten m ikke anvendes til andre
lgemidler. PREZISTA fs ogs som 75 mg, 150 mg, 400 mg, 600 mg og 800
mg filmovertrukne tabletter. Indehaver af markedsfringstilladelsen
Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, Belgien
Fremstiller Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse,
Belgien Hvis du nsker yderligere oplysninger om dette lgemiddel, skal
du henvende dig til den lokale reprsentant for indehaveren af
markedsfringstilladelsen: Belgi/Belgique/Belgien Janssen-Cilag NV
Tel/Tl: +32 14 64 94 11 <a
href="mailto:janssen@jacbe.jnj.com">janssen@jacbe.jnj.com</a> Lietuva
UAB "JOHNSON &amp; JOHNSON" Tel: +370 5 278 68 88 <a
href="mailto:lt@its.jnj.com">lt@its.jnj.com</a>   &amp;
 "  .: +359 2 489 94 00 <a
href="mailto:jjsafety@its.jnj.com">jjsafety@its.jnj.com</a>
Luxembourg/Luxemburg Janssen-Cilag NV Tl/Tel: +32 14 64 94 11 <a
href="mailto:janssen@jacbe.jnj.com">janssen@jacbe.jnj.com</a> esk
republika Janssen-Cilag s.r.o. Tel: +420 227 012 227 Magyarorszg
Janssen-Cilag Kft. Tel.: +36 1 884 2858 <a
href="mailto:janssenhu@its.jnj.com">janssenhu@its.jnj.com</a> Danmark
Janssen-Cilag A/S Tlf: +45 4594 8282 <a
href="mailto:jacdk@its.jnj.com">jacdk@its.jnj.com</a> Malta AM MANGION
LTD Tel: +356 2397 6000 Deutschland Janssen-Cilag GmbH Tel: +49 2137 955
955 <a href="mailto:jancil@its.jnj.com">jancil@its.jnj.com</a> Nederland
Janssen-Cilag B.V. Tel: +31 76 711 1111 <a
href="mailto:janssen@jacnl.jnj.com">janssen@jacnl.jnj.com</a> Eesti UAB
"JOHNSON &amp; JOHNSON" Eesti filiaal Tel: +372 617 7410 <a
href="mailto:ee@its.jnj.com">ee@its.jnj.com</a> Norge Janssen-Cilag AS
Tlf: +47 24 12 65 00 <a
href="mailto:jacno@its.jnj.com">jacno@its.jnj.com</a> 
Janssen-Cilag  .... T: +30 210 80 90 000 sterreich
Janssen-Cilag Pharma GmbH Tel: +43 1 610 300 Espaa Janssen-Cilag, S.A.
Tel: +34 91 722 81 00 <a
href="mailto:contacto@its.jnj.com">contacto@its.jnj.com</a> Polska
Janssen-Cilag Polska Sp. z o.o. Tel.: +48 22 237 60 00 153 France
Janssen-Cilag Tl: 0 800 25 50 75 / +33 1 55 00 40 03 <a
href="mailto:medisource@its.jnj.com">medisource@its.jnj.com</a> Portugal
Janssen-Cilag Farmacutica, Lda. Tel: +351 214 368 600 Hrvatska Johnson
&amp; Johnson S.E. d.o.o. Tel: +385 1 6610 700 <a
href="mailto:jjsafety@JNJCR.JNJ.com">jjsafety@JNJCR.JNJ.com</a> Romnia
Johnson &amp; Johnson Romnia SRL Tel: +40 21 207 1800 Ireland Janssen
Sciences Ireland UC Tel: +353 1 800 709 122 Slovenija Johnson &amp;
Johnson d.o.o. Tel: +386 1 401 18 00 <a
href="mailto:Janssen_safety_slo@its.jnj.com">Janssen_safety_slo@its.jnj.com</a>
sland Janssen-Cilag AB c/o Vistor hf. Smi: +354 535 7000 <a
href="mailto:janssen@vistor.is">janssen@vistor.is</a> Slovensk
republika Johnson &amp; Johnson, s.r.o. Tel: +421 232 408 400 Italia
Janssen-Cilag SpA Tel: 800.688.777 / +39 02 2510 1 <a
href="mailto:janssenita@its.jnj.com">janssenita@its.jnj.com</a>
Suomi/Finland Janssen-Cilag Oy Puh/Tel: +358 207 531 300 <a
href="mailto:jacfi@its.jnj.com">jacfi@its.jnj.com</a>  
  : +357 22 207 700 Sverige Janssen-Cilag AB Tfn: +46
8 626 50 00 <a href="mailto:jacse@its.jnj.com">jacse@its.jnj.com</a>
Latvija UAB "JOHNSON &amp; JOHNSON" filile Latvij Tel: +371 678 93561
<a href="mailto:lv@its.jnj.com">lv@its.jnj.com</a> United Kingdom
(Northern Ireland) Janssen Sciences Ireland UC Tel: +44 1 494 567 444
Denne indlgsseddel blev senest ndret {MM/} Du kan finde yderligere
oplysninger om dette lgemiddel p Det Europiske Lgemiddelagenturs
hjemmeside <a
href="http://www.ema.europa.eu">http://www.ema.europa.eu</a>. 154
Indlgsseddel: Information til brugeren PREZISTA 75 mg filmovertrukne
tabletter darunavir Ls denne indlgsseddel grundigt, inden du begynder
at tage dette lgemiddel, da den indeholder vigtige oplysninger.</h2>
<h2 id="gem-indlgssedlen-du-kan-f-brug-for-at-lse-den-igen">Gem
indlgssedlen. Du kan f brug for at lse den igen.</h2>
<h2
id="sprg-lgen-apotekspersonalet-eller-sygeplejersken-hvis-der-er-mere-du-vil-vide">Sprg
lgen, apotekspersonalet eller sygeplejersken, hvis der er mere du vil
vide.</h2>
<h2
id="lgen-har-ordineret-dette-lgemiddel-til-dig-personligt-lad-derfor-vre-med-at-give-medicinen-til-andre-det-kan-vre-skadeligt-for-andre-selvom-de-har-de-samme-symptomer-som-du-har">Lgen
har ordineret dette lgemiddel til dig personligt. Lad derfor vre med
at give medicinen til andre. Det kan vre skadeligt for andre, selvom de
har de samme symptomer, som du har.</h2>
<p>Kontakt lgen, apotekspersonalet eller sygeplejersken, hvis du fr
bivirkninger, herunder bivirkninger, som ikke er nvnt i denne
indlgsseddel. Se punkt 4. Se den nyeste indlgsseddel p <a
href="http://www.indlaegsseddel.dk">www.indlaegsseddel.dk</a>.</p>
 </div>"""      



Instance: composition-pt-c73255ba16f112f8e9f93b50083ae06f
InstanceOf: CompositionUvEpi
Title: "Composition for prezista Package Leaflet"
Description:  "Composition for prezista Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "EU/1/06/380/006"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpc73255ba16f112f8e9f93b50083ae06f)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - prezista"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #pt
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. FOLHETO INFORMATIVO"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. FOLHETO INFORMATIVO"
  * text.status = #additional

  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>unavailable</div>"""
  * emptyReason = http://terminology.hl7.org/CodeSystem/list-empty-reason#unavailable   


      
* section[=].section[+]
  * title = "Folheto informativo: Informao para o utilizador"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Folheto informativo: Informao para o utilizador"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  
  </div>"""   



* section[=].section[+]
  * title = "O que contm este folheto"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "O que contm este folheto"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>O que contm este folheto:</p>
<ol type="1">
<li>O que  PREZISTA e para que  utilizado</li>
<li>O que precisa de saber antes de tomar PREZISTA</li>
<li>Como tomar PREZISTA</li>
<li>Efeitos indesejveis possveis</li>
<li>Como conservar PREZISTA</li>
<li>Contedo da embalagem e outras informaes</li>
</ol>
 </div>"""   
          

* section[=].section[+]
  * title =  "1. O que  prezista e para que  utilizado"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. O que  prezista e para que  utilizado"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>O que  PREZISTA? PREZISTA contm a substncia ativa darunavir.
PREZISTA  um medicamento antirretroviral, utilizado no tratamento da
infeo pelo Vrus da Imunodeficincia Humana (VIH). Pertence a um grupo
de medicamentos denominado inibidores da protease. PREZISTA atua
reduzindo a quantidade de VIH presente no seu corpo. Desta forma, ir
melhorar o seu sistema imunolgico e reduzir o risco de desenvolvimento
de doenas associadas  infeo pelo VIH. Para que  utilizado? PREZISTA
 utilizado no tratamento de adultos e crianas com idade igual ou
superior a 3 anos e com, pelo menos, 15 quilogramas de peso corporal
infetados pelo VIH (ver Como tomar PREZISTA). PREZISTA deve ser
administrado em associao com uma dose baixa de cobicistate ou
ritonavir e outros medicamentos anti-VIH. O seu mdico falar consigo
sobre qual ser a associao de medicamentos melhor para o seu caso.</p>
 </div>"""   
          

             
* section[=].section[+]
  * title = "2. O que precisa de saber antes de tomar prezista"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. O que precisa de saber antes de tomar prezista"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2 id="no-tome-prezista">No tome PREZISTA</h2>
<h2
id="se-tem-alergia-ao-darunavir-a-qualquer-outro-componente-deste-medicamento-indicados-na-seco-6-ou-ao-cobicistate-ou-ritonavir">se
tem alergia ao darunavir, a qualquer outro componente deste medicamento
(indicados na seco 6) ou ao cobicistate ou ritonavir.</h2>
<h2
id="se-tem-problemas-de-fgado-graves-pergunte-ao-seu-mdico-se-no-tem-a-certeza-sobre-a-gravidade-do-seu-problema-de-fgado-alguns-testes-adicionais-podero-ser-necessrios-fale-com-o-seu-mdico-sobre-todos-os-medicamentos-que-est-a-tomar-incluindo-medicamentos-tomados-por-via-oral-inalados-injetados-ou-aplicados-na-pele-no-combine-prezista-com-qualquer-um-dos-seguintes-medicamentos-se-estiver-a-utilizar-qualquer-um-destes-medicamentos-consulte-o-seu-mdico-sobre-a-possibilidade-de-mudar-para-outro-medicamento-155-medicamento-ao-do-medicamento-avanafil-para-tratamento-da-disfuno-ertil-astemizol-ou-terfenadina-para-tratamento-dos-sintomas-de-alergia-triazolam-e-midazolam-oral-tomado-pela-boca-para-ajudar-a-dormir-eou-aliviar-a-ansiedade-cisaprida-para-tratamento-de-algumas-perturbaes-gstricas-colquicina-se-tem-problemas-nos-rins-eou-no-fgado-para-tratamento-da-gota-ou-febre-mediterrnica-familiar-lurasidona-pimozida-quetiapina-ou-sertindol-para-tratamento-de-perturbaes-psiquitricas-alcaloides-da-ergotamina-como-ergotamina-di--hidroergotamina-ergometrina-e-metilergonovina-para-tratamento-da-enxaqueca-amiodarona-bepridilo-drodenarona-ivabradina-quinidina-ranolazina-para-tratamento-de-certas-doenas-do-corao-por-exemplo-batimento-cardaco-anormal-lovastatina-sinvastatina-e-lomitapida-para-baixar-os-nveis-de-colesterol-rifampicina-para-o-tratamento-de-algumas-infees-como-a-tuberculose-o-medicamento-de-associao-lopinavirritonavir-este-medicamento-anti-vih-pertence--mesma-classe-que-prezista-elbasvirgrazoprevir-para-o-tratamento-da-infeo-pelo-vrus-da-hepatite-c-alfuzosina-para-tratamento-da-prstata-aumentada-sildenafil-para-tratamento-da-presso-arterial-elevada-na-circulao-pulmonar-ticagrelor-para-ajudar-a-impedir-a-agregao-de-plaquetas-no-tratamento-de-doentes-com-histria-de-ataque-cardaco-naloxegol-para-tratamento-da-obstipao-induzida-por-opioides-dapoxetina-para-tratamento-da-ejaculao-precoce-domperidona-para-tratamento-de-nuseas-e-vmitos-no-utilize-prezista-em-combinao-com-outros-produtos-contendo-hiperico-hypericum-perforatum-advertncias-e-precaues-fale-com-o-seu-mdico-farmacutico-ou-enfermeiro-antes-de-tomar-prezista-prezista-no--uma-cura-para-a-infeo-pelo-vih-os-indivduos-que-tomam-prezista-podem-continuar-a-desenvolver-infees-ou-outras-doenas-associadas--infeo-por-vih-deve-manter-um-contacto-regular-com-o-seu-mdico-os-indivduos-a-tomar-prezista-podem-desenvolver-uma-erupo-na-pele-pouco-frequentemente-uma-erupo-na-pele-pode-tornar-se-grave-ou-potencialmente-fatal-contacte-por-favor-o-seu-mdico-sempre-que-desenvolver-uma-erupo-na-pele-as-erupes-na-pele-geralmente-ligeiras-ou-moderadas-podem-ocorrer-mais-frequentemente-nos-doentes-a-tomar-prezista-e-raltegravir-para-infeo-por-vih-do-que-nos-doentes-a-tomar-os-medicamentos-em-separado-informe-o-seu-mdico-sobre-a-sua-situao-antes-e-durante-o-seu-tratamento-assegure-se-que-rev-os-pontos-a-seguir-referidos-e-informe-o-seu-mdico-se-algum--aplicvel--sua-situao-156">se
tem problemas de fgado graves. Pergunte ao seu mdico se no tem a
certeza sobre a gravidade do seu problema de fgado. Alguns testes
adicionais podero ser necessrios. Fale com o seu mdico sobre todos os
medicamentos que est a tomar, incluindo medicamentos tomados por via
oral, inalados, injetados ou aplicados na pele. No combine PREZISTA com
qualquer um dos seguintes medicamentos Se estiver a utilizar qualquer um
destes medicamentos consulte o seu mdico sobre a possibilidade de mudar
para outro medicamento. 155 Medicamento Ao do medicamento Avanafil
para tratamento da disfuno ertil Astemizol ou terfenadina para
tratamento dos sintomas de alergia Triazolam e midazolam oral (tomado
pela boca) para ajudar a dormir e/ou aliviar a ansiedade Cisaprida para
tratamento de algumas perturbaes gstricas Colquicina (se tem
problemas nos rins e/ou no fgado) para tratamento da gota ou febre
Mediterrnica familiar Lurasidona, pimozida, quetiapina ou sertindol
para tratamento de perturbaes psiquitricas Alcaloides da ergotamina,
como ergotamina, di- hidroergotamina, ergometrina e metilergonovina para
tratamento da enxaqueca Amiodarona, bepridilo, drodenarona, ivabradina,
quinidina, ranolazina para tratamento de certas doenas do corao, por
exemplo: batimento cardaco anormal Lovastatina, sinvastatina e
lomitapida para baixar os nveis de colesterol Rifampicina para o
tratamento de algumas infees como a tuberculose O medicamento de
associao lopinavir/ritonavir este medicamento anti-VIH pertence 
mesma classe que PREZISTA Elbasvir/grazoprevir para o tratamento da
infeo pelo vrus da hepatite C Alfuzosina para tratamento da prstata
aumentada Sildenafil para tratamento da presso arterial elevada na
circulao pulmonar Ticagrelor para ajudar a impedir a agregao de
plaquetas no tratamento de doentes com histria de ataque cardaco
Naloxegol para tratamento da obstipao induzida por opioides Dapoxetina
para tratamento da ejaculao precoce Domperidona para tratamento de
nuseas e vmitos No utilize PREZISTA em combinao com outros produtos
contendo hiperico (Hypericum perforatum). Advertncias e precaues
Fale com o seu mdico, farmacutico ou enfermeiro antes de tomar
PREZISTA. PREZISTA no  uma cura para a infeo pelo VIH. Os indivduos
que tomam PREZISTA podem continuar a desenvolver infees ou outras
doenas associadas  infeo por VIH. Deve manter um contacto regular
com o seu mdico. Os indivduos a tomar PREZISTA podem desenvolver uma
erupo na pele. Pouco frequentemente uma erupo na pele pode tornar-se
grave ou potencialmente fatal. Contacte, por favor, o seu mdico sempre
que desenvolver uma erupo na pele. As erupes na pele (geralmente
ligeiras ou moderadas) podem ocorrer mais frequentemente nos doentes a
tomar PREZISTA e raltegravir (para infeo por VIH) do que nos doentes a
tomar os medicamentos em separado. Informe o seu mdico sobre a sua
situao ANTES e DURANTE o seu tratamento Assegure-se que rev os pontos
a seguir referidos e informe o seu mdico se algum  aplicvel  sua
situao. 156</h2>
<h2
id="informe-o-seu-mdico-se-j-teve-problemas-de-fgado-incluindo-infeo-pelo-vrus-da-hepatite-b-ou-c-o-seu-mdico-poder-avaliar-o-grau-de-gravidade-da-sua-doena-heptica-antes-de-decidir-se-pode-tomar-prezista">Informe
o seu mdico se j teve problemas de fgado, incluindo infeo pelo
vrus da hepatite B ou C. O seu mdico poder avaliar o grau de
gravidade da sua doena heptica antes de decidir se pode tomar
PREZISTA.</h2>
<h2
id="informe-o-seu-mdico-se-tem-diabetes-prezista-pode-aumentar-os-nveis-de-acar-no-sangue">Informe
o seu mdico se tem diabetes. PREZISTA pode aumentar os nveis de acar
no sangue.</h2>
<h2
id="informe-imediatamente-o-seu-mdico-se-apresentar-quaisquer-sintomas-de-infeo-por-exemplo-inchao-dos-gnglios-linfticos-e-febre-alguns-doentes-com-infeo-pelo-vih-avanada-e-antecedentes-de-uma-infeo-oportunista-podem-desenvolver-sinais-e-sintomas-de-inflamao-resultantes-de-uma-infeo-anterior-logo-aps-iniciar-um-tratamento-anti-vih-pensa-se-que-estes-sintomas-so-devidos-a-uma-melhoria-da-resposta-imunolgica-do-organismo-que-permite-ao-organismo-combater-as-infees-que-se-encontrem-eventualmente-presentes-sem-sintomas-bvios">Informe
imediatamente o seu mdico se apresentar quaisquer sintomas de infeo
(por exemplo, inchao dos gnglios linfticos e febre). Alguns doentes
com infeo pelo VIH avanada e antecedentes de uma infeo oportunista,
podem desenvolver sinais e sintomas de inflamao resultantes de uma
infeo anterior logo aps iniciar um tratamento anti-VIH. Pensa-se que
estes sintomas so devidos a uma melhoria da resposta imunolgica do
organismo, que permite ao organismo combater as infees que se
encontrem eventualmente presentes sem sintomas bvios.</h2>
<h2
id="adicionalmente-s-infees-oportunistas-as-doenas-autoimunes-uma-condio-que-ocorre-quando-o-sistema-imunitrio-ataca-tecidos-corporais-saudveis-tambm-podem-ocorrer-depois-de-comear-a-tomar-os-medicamentos-para-o-tratamento-da-sua-infeo-pelo-vih-as-doenas-autoimunes-podem-ocorrer-muitos-meses-aps-o-incio-do-tratamento-se-notar-quaisquer-sintomas-de-infeo-ou-outros-sintomas-como-fraqueza-muscular-fraqueza-a-comear-nas-mos-e-nos-ps-e-dirigindo-se-em-direo-ao-tronco-palpitaes-tremores-ou-hiperatividade-informe-o-seu-mdico-imediatamente-para-procurar-o-tratamento-necessrio">Adicionalmente
s infees oportunistas, as doenas autoimunes (uma condio que ocorre
quando o sistema imunitrio ataca tecidos corporais saudveis) tambm
podem ocorrer depois de comear a tomar os medicamentos para o
tratamento da sua infeo pelo VIH. As doenas autoimunes podem ocorrer
muitos meses aps o incio do tratamento. Se notar quaisquer sintomas de
infeo ou outros sintomas como fraqueza muscular, fraqueza a comear
nas mos e nos ps e dirigindo-se em direo ao tronco, palpitaes,
tremores ou hiperatividade, informe o seu mdico imediatamente para
procurar o tratamento necessrio.</h2>
<h2
id="informe-o-seu-mdico-se-tem-hemofilia-prezista-pode-aumentar-o-risco-de-hemorragia">Informe
o seu mdico se tem hemofilia. PREZISTA pode aumentar o risco de
hemorragia.</h2>
<h2
id="informe-o-seu-mdico-se--alrgico-a-sulfonamidas-ex-utilizadas-para-tratar-certas-infees">Informe
o seu mdico se  alrgico a sulfonamidas (ex.: utilizadas para tratar
certas infees).</h2>
<h2
id="informe-o-seu-mdico-se-notar-alguns-problemas-musculoesquelticos-alguns-doentes-que-tomam-teraputica-antirretroviral-combinada-podem-desenvolver-uma-doena-nos-ossos-denominada-osteonecrose-morte-do-tecido-sseo-causada-por-uma-perda-de-fornecimento-de-sangue-aos-ossos-alguns-dos-vrios-fatores-de-risco-para-o-desenvolvimento-desta-doena-so-a-durao-da-teraputica-antirretroviral-combinada-utilizao-de-corticosteroides-consumo-de-lcool-imunodepresso-grave-e-ndice-de-massa-corporal-elevado-os-sinais-da-osteonecrose-so-rigidez-nas-articulaes-dores-especialmente-na-anca-joelho-e-ombro-ou-dificuldade-nos-movimentos-se-notar-qualquer-destes-sintomas-por-favor-informe-o-seu-mdico-idosos-prezista-foi-administrado-a-um-nmero-limitado-de-doentes-com-idade-igual-ou-superior-a-65-anos-se-pertence-a-este-grupo-etrio-fale-com-o-seu-mdico-para-saber-se-pode-utilizar-prezista-crianas-prezista-no--para-ser-tomado-por-crianas-com-menos-de-3-anos-de-idade-ou-com-peso-inferior-a-15-quilogramas-outros-medicamentos-e-prezista-informe-o-seu-mdico-se-estiver-a-tomar-ou-tiver-tomado-recentemente-outros-medicamentos-existem-alguns-medicamentos-que-no-poder-combinar-com-prezista-estes-so-mencionados-no-ttulo-no-combine-prezista-com-qualquer-um-dos-seguintes-medicamentos-na-maioria-dos-casos-prezista-pode-ser-combinado-com-outros-medicamentos-anti-vih-pertencentes-a-outra-classe-de-medicamentos-por-exemplo-nrtis-anlogos-dos-nucleosdeos-inibidores-da-transcriptase-reversa-nnrtis-anlogos-no-nucleosdeos-inibidores-da-transcriptase-reversa-antagonistas-dos-recetores-ccr5-e-ifs-inibidores-da-fuso-a-associao-de-prezista-com-cobicistate-ou-ritonavir-no-foi-testada-com-todos-os-ips-inibidores-da-protease-e-no-deve-ser-utilizado-com-outros-ips-do-vih-em-alguns-casos-pode-ser-necessrio-alterar-a-dose-de-outros-medicamentos-assim-informe-sempre-o-seu-mdico-se-est-a-tomar-outro-medicamento-anti-vih-e-siga-cuidadosamente-as-suas-instrues-sobre-que-medicamentos-podem-ser-associados-os-efeitos-de-prezista-podem-ser-reduzidos-se-utilizar-qualquer-um-dos-seguintes-medicamentos-informe-o-seu-mdico-se-est-a-tomar">Informe
o seu mdico se notar alguns problemas musculoesquelticos. Alguns
doentes que tomam teraputica antirretroviral combinada podem
desenvolver uma doena nos ossos denominada osteonecrose (morte do
tecido sseo causada por uma perda de fornecimento de sangue aos ossos).
Alguns dos vrios fatores de risco para o desenvolvimento desta doena
so a durao da teraputica antirretroviral combinada, utilizao de
corticosteroides, consumo de lcool, imunodepresso grave e ndice de
massa corporal elevado. Os sinais da osteonecrose so rigidez nas
articulaes, dores (especialmente na anca, joelho e ombro) ou
dificuldade nos movimentos. Se notar qualquer destes sintomas, por favor
informe o seu mdico. Idosos PREZISTA foi administrado a um nmero
limitado de doentes com idade igual ou superior a 65 anos. Se pertence a
este grupo etrio, fale com o seu mdico para saber se pode utilizar
PREZISTA. Crianas PREZISTA no  para ser tomado por crianas com menos
de 3 anos de idade ou com peso inferior a 15 quilogramas. Outros
medicamentos e PREZISTA Informe o seu mdico se estiver a tomar ou tiver
tomado recentemente outros medicamentos. Existem alguns medicamentos que
no poder combinar com PREZISTA. Estes so mencionados no ttulo No
combine PREZISTA com qualquer um dos seguintes medicamentos". Na maioria
dos casos, PREZISTA pode ser combinado com outros medicamentos anti-VIH,
pertencentes a outra classe de medicamentos [por exemplo: NRTIs
(anlogos dos nucleosdeos inibidores da transcriptase reversa), NNRTIs
(anlogos no nucleosdeos inibidores da transcriptase reversa),
antagonistas dos recetores CCR5 e IFs (inibidores da fuso)]. A
associao de PREZISTA com cobicistate ou ritonavir no foi testada com
todos os IPs (inibidores da protease) e no deve ser utilizado com
outros IPs do VIH. Em alguns casos, pode ser necessrio alterar a dose
de outros medicamentos. Assim, informe sempre o seu mdico se est a
tomar outro medicamento anti-VIH e siga cuidadosamente as suas
instrues sobre que medicamentos podem ser associados. Os efeitos de
PREZISTA podem ser reduzidos se utilizar qualquer um dos seguintes
medicamentos. Informe o seu mdico se est a tomar:</h2>
<h2 id="fenobarbital-fenitona-para-prevenir-convulses">Fenobarbital,
fenitona (para prevenir convulses)</h2>
<h2 id="dexametasona-corticosteroide-157">Dexametasona (corticosteroide)
157</h2>
<h2 id="efavirenz-infeo-pelo-vih">Efavirenz (infeo pelo VIH)</h2>
<h2
id="rifapentina-rifabutina-medicamentos-para-tratamento-de-algumas-infees-como-a-tuberculose">Rifapentina,
rifabutina (medicamentos para tratamento de algumas infees como a
tuberculose)</h2>
<h2
id="saquinavir-infeo-pelo-vih-os-efeitos-de-outros-medicamentos-podem-ser-afetados-pelo-tratamento-com-prezista-e-o-seu-mdico-poder-querer-fazer-algumas-anlises-ao-sangue-adicionais-informe-o-seu-mdico-se-est-a-tomar">Saquinavir
(infeo pelo VIH) Os efeitos de outros medicamentos podem ser afetados
pelo tratamento com PREZISTA e o seu mdico poder querer fazer algumas
anlises ao sangue adicionais. Informe o seu mdico se est a
tomar:</h2>
<h2
id="amlodipina-diltiazem-disopiramida-carvedilol-felodipina-flecainida-lidocana-metoprolol-mexiletina-nifedipina-nicardipina-propafenona-timolol-verapamilo-para-doenas-do-corao-uma-vez-que-o-efeito-teraputico-ou-os-efeitos-indesejveis-destes-medicamentos-podem-ser-aumentados">Amlodipina,
diltiazem, disopiramida, carvedilol, felodipina, flecainida, lidocana,
metoprolol, mexiletina, nifedipina, nicardipina, propafenona, timolol,
verapamilo (para doenas do corao), uma vez que o efeito teraputico
ou os efeitos indesejveis destes medicamentos podem ser
aumentados.</h2>
<h2
id="apixabano-dabigatrano-etexilato-edoxabano-rivaroxabano-varfarina-clopidogrel-para-reduzir-a-coagulao-do-sangue-uma-vez-que-o-efeito-teraputico-ou-os-efeitos-indesejveis-deste-medicamento-podem-estar-alterados">Apixabano,
dabigatrano etexilato, edoxabano, rivaroxabano, varfarina, clopidogrel
(para reduzir a coagulao do sangue), uma vez que o efeito teraputico
ou os efeitos indesejveis deste medicamento podem estar alterados.</h2>
<h2
id="contracetivos-orais--base-de-estrognios-e-teraputica-hormonal-de-substituio-prezista-pode-reduzir-a-sua-eficcia-quando-utilizado-para-controlo-da-natalidade-so-recomendados-mtodos-contracetivos-no-hormonais-alternativos">Contracetivos
orais  base de estrognios e teraputica hormonal de substituio.
PREZISTA pode reduzir a sua eficcia. Quando utilizado para controlo da
natalidade so recomendados mtodos contracetivos no hormonais
alternativos.</h2>
<h2
id="etinilestradioldrospirenona-prezista-pode-aumentar-o-risco-de-nveis-elevados-de-potssio-causados-pela-drospirenona">Etinilestradiol/drospirenona.
PREZISTA pode aumentar o risco de nveis elevados de potssio causados
pela drospirenona.</h2>
<h2
id="atorvastatina-pravastatina-rosuvastatina-para-baixar-os-nveis-de-colesterol-pode-observar-se-um-aumento-do-risco-de-dano-muscular-o-seu-mdico-avaliar-qual-o-regime-mais-adequado-para-baixar-os-nveis-de-colesterol-para-a-sua-situao-especfica">Atorvastatina,
pravastatina, rosuvastatina (para baixar os nveis de colesterol). Pode
observar-se um aumento do risco de dano muscular. O seu mdico avaliar
qual o regime mais adequado para baixar os nveis de colesterol para a
sua situao especfica.</h2>
<h2 id="claritromicina-antibitico">Claritromicina (antibitico).</h2>
<h2
id="ciclosporina-everolmus-tacrolmus-sirolmus-para-diminuir-a-ao-do-seu-sistema-imunolgico-uma-vez-que-o-efeito-teraputico-ou-os-efeitos-indesejveis-destes-medicamentos-podem-ser-aumentados">Ciclosporina,
everolmus, tacrolmus, sirolmus (para diminuir a ao do seu sistema
imunolgico) uma vez que o efeito teraputico ou os efeitos indesejveis
destes medicamentos podem ser aumentados.</h2>
<h2
id="corticosteroides-incluindo-betametasona-budesonida-fluticasona-mometasona-prednisona-triamcinolona-estes-medicamentos-so-utilizados-para-tratar-alergias-asma-doenas-inflamatrias-intestinais-condies-inflamatrias-da-pele-dos-olhos-articulaes-e-msculos-e-outras-condies-inflamatrias-estes-medicamentos-so-habitualmente-tomados-por-via-oral-inalados-injetados-ou-aplicados-na-pele-se-no-puderem-ser-utilizadas-alternativas-a-sua-utilizao-s-pode-ocorrer-aps-avaliao-mdica-e-sob-monitorizao-cuidada-por-parte-do-seu-mdico-relativamente-a-efeitos-indesejveis-dos-corticosteroides">Corticosteroides
incluindo betametasona, budesonida, fluticasona, mometasona, prednisona,
triamcinolona. Estes medicamentos so utilizados para tratar alergias,
asma, doenas inflamatrias intestinais, condies inflamatrias da
pele, dos olhos, articulaes e msculos e outras condies
inflamatrias. Estes medicamentos so, habitualmente, tomados por via
oral, inalados, injetados ou aplicados na pele. Se no puderem ser
utilizadas alternativas, a sua utilizao s pode ocorrer aps avaliao
mdica e sob monitorizao cuidada por parte do seu mdico relativamente
a efeitos indesejveis dos corticosteroides.</h2>
<h2
id="buprenorfinanaloxona-medicamentos-para-tratamento-da-dependncia-de-opioides">Buprenorfina/naloxona
(medicamentos para tratamento da dependncia de opioides)</h2>
<h2 id="salmeterol-medicamento-para-tratar-a-asma">Salmeterol
(medicamento para tratar a asma)</h2>
<h2
id="artemterlumefantrina-uma-combinao-de-medicamentos-para-o-tratamento-da-malria">Artemter/lumefantrina
(uma combinao de medicamentos para o tratamento da malria)</h2>
<h2
id="dasatinib-everolmus-irinotecano-nilotinib-vinblastina-vincristina-para-tratamento-do-cancro">Dasatinib,
everolmus, irinotecano, nilotinib, vinblastina, vincristina (para
tratamento do cancro)</h2>
<h2
id="sildenafil-tadalafil-vardenafil-para-a-disfuno-ertil-ou-para-tratar-um-problema-do-corao-e-pulmes-chamado-hipertenso-arterial-pulmonar">Sildenafil,
tadalafil, vardenafil (para a disfuno ertil ou para tratar um
problema do corao e pulmes chamado hipertenso arterial
pulmonar)</h2>
<h2
id="glecaprevirpibrentasvir-para-tratar-a-infeo-pelo-vrus-da-hepatite-c">Glecaprevir/pibrentasvir
(para tratar a infeo pelo vrus da hepatite C)</h2>
<h2 id="fentanilo-oxicodona-tramadol-para-tratamento-da-dor">Fentanilo,
oxicodona, tramadol (para tratamento da dor)</h2>
<h2
id="fesoterodina-solifenacina-para-tratamento-de-distrbios-urolgicos-o-seu-mdico-poder-querer-fazer-algumas-anlises-ao-sangue-adicionais-e-poder-ser-necessrio-alterar-a-dose-de-outros-medicamentos-uma-vez-que-os-efeitos-teraputicos-ou-os-efeitos-indesejveis-destes-medicamentos-ou-de-prezista-podem-ser-influenciados-quando-associados-informe-o-seu-mdico-se-est-a-utilizar">Fesoterodina,
solifenacina (para tratamento de distrbios urolgicos). O seu mdico
poder querer fazer algumas anlises ao sangue adicionais e poder ser
necessrio alterar a dose de outros medicamentos, uma vez que os efeitos
teraputicos ou os efeitos indesejveis destes medicamentos ou de
PREZISTA podem ser influenciados quando associados. Informe o seu mdico
se est a utilizar:</h2>
<h2
id="dabigatrano-etexilato-edoxabano-varfarina-para-diminuir-a-coagulao-do-sangue">Dabigatrano
etexilato, edoxabano, varfarina (para diminuir a coagulao do
sangue)</h2>
<h2
id="alfentanilo-analgsico-injetvel-forte-e-de-curta-durao-utilizado-em-procedimentos-cirrgicos">Alfentanilo
(analgsico injetvel forte e de curta durao utilizado em
procedimentos cirrgicos)</h2>
<h2 id="digoxina-para-tratar-certas-doenas-do-corao">Digoxina (para
tratar certas doenas do corao)</h2>
<h2 id="claritromicina-antibitico-1">Claritromicina (antibitico)</h2>
<h2
id="itraconazol-isavuconazol-fluconazol-posaconazol-clotrimazol-para-tratar-infees-fngicas-o-voriconazol-deve-apenas-ser-tomado-aps-avaliao-clnica">Itraconazol,
isavuconazol, fluconazol, posaconazol, clotrimazol (para tratar infees
fngicas). O voriconazol deve apenas ser tomado aps avaliao
clnica.</h2>
<h2 id="rifabutina-contra-infees-bacterianas-158">Rifabutina (contra
infees bacterianas) 158</h2>
<h2
id="sildenafil-vardenafil-tadalafil-para-a-disfuno-ertil-ou-presso-arterial-elevada-na-circulao-pulmonar">Sildenafil,
vardenafil, tadalafil (para a disfuno ertil ou presso arterial
elevada na circulao pulmonar)</h2>
<h2
id="amitriptilina-desipramina-imipramina-nortriptilina-paroxetina-sertralina-trazodona-para-tratamento-da-depresso-e-ansiedade">Amitriptilina,
desipramina, imipramina, nortriptilina, paroxetina, sertralina,
trazodona (para tratamento da depresso e ansiedade)</h2>
<h2 id="maraviroc-para-tratar-a-infeo-pelo-vih">Maraviroc (para tratar
a infeo pelo VIH)</h2>
<h2 id="metadona-para-tratar-a-dependncia-opioide">Metadona (para
tratar a dependncia opioide)</h2>
<h2
id="carbamazepina-clonazepam-para-prevenir-as-convulses-ou-para-o-tratamento-de-certos-tipos-de-dor-no-nervo">Carbamazepina,
clonazepam (para prevenir as convulses ou para o tratamento de certos
tipos de dor no nervo)</h2>
<h2
id="colquicina-para-tratar-a-gota-ou-febre-mediterrnica-familiar">Colquicina
(para tratar a gota ou febre Mediterrnica familiar)</h2>
<h2
id="bosentano-para-tratar-a-presso-arterial-elevada-na-circulao-pulmonar">Bosentano
(para tratar a presso arterial elevada na circulao pulmonar)</h2>
<h2
id="buspirona-clorazepato-diazepam-estazolam-flurazepam-midazolam-quando-usado-sob-a-forma-de-injeo-zolpidem-agentes-sedativos">Buspirona,
clorazepato, diazepam, estazolam, flurazepam, midazolam quando usado sob
a forma de injeo, zolpidem (agentes sedativos)</h2>
<h2
id="perfenazina-risperidona-tioridazina-para-tratar-condies-psiquitricas">Perfenazina,
risperidona, tioridazina (para tratar condies psiquitricas)</h2>
<p>Metformina (para tratar a diabetes tipo 2). Esta no  uma lista
completa de medicamentos. Informe o seu mdico sobre todos os
medicamentos que est a tomar. PREZISTA com alimentos e bebidas Ver a
seco 3 Como tomar PREZISTA". Gravidez e amamentao Informe
imediatamente o seu mdico se est grvida ou se planeia engravidar. As
mulheres grvidas no devem tomar PREZISTA com ritonavir, a no ser se
especificamente recomendado pelo mdico. As mulheres grvidas no devem
tomar PREZISTA com cobicistate. Devido ao potencial de efeitos
indesejveis em lactentes amamentados, as mulheres no devem amamentar
se estiverem a ser tratadas com PREZISTA. A amamentao no 
recomendada em mulheres que vivem com VIH porque a infeo pelo VIH pode
passar para o beb atravs do leite materno. Se est a amamentar ou
pensa em amamentar, dever, assim que possvel, aconselhar-se com o seu
mdico. Conduo de veculos e utilizao de mquinas No conduza nem
utilize quaisquer mquinas caso sinta tonturas aps tomar PREZISTA.
PREZISTA suspenso oral contm para-hidroxibenzoato de metilo sdico.
Este ingrediente pode causar reaes alrgicas (por vezes retardadas).
PREZISTA contm sdio Este medicamento contm menos do que 1 mmol de
sdio (23 mg) por ml, ou seja,  praticamente isento de sdio".</p>
 </div>"""   
                    
* section[=].section[+]
  * title =  "3. Como tomar prezista"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. Como tomar prezista"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2
id="tome-este-medicamento-exatamente-como-est-descrito-neste-folheto-ou-conforme-indicado-pelo-seu-mdico-farmacutico-ou-enfermeiro-fale-com-o-seu-mdico-farmacutico-ou-enfermeiro-se-tiver-dvidas-mesmo-que-se-sinta-melhor-no-deixe-de-tomar-prezista-e-cobicistate-ou-ritonavir-sem-falar-com-o-seu-mdico-aps-o-tratamento-ter-sido-iniciado-a-dose-ou-a-forma-de-apresentao-no-devem-ser-alteradas-ou-o-tratamento-no-deve-ser-interrompido-sem-indicao-do-seu-mdico-159-dose-para-crianas-com-idade-igual-ou-superior-a-3-anos-que-pesem-pelo-menos-15-quilogramas-e-que-ainda-no-tenham-tomado-medicamentos-antirretrovirais-anteriormente-o-mdico-da-sua-criana-ir-determinar-isto-o-mdico-ir-determinar-qual-a-dose-correta-a-administrar-uma-vez-por-dia-com-base-no-peso-e-idade-da-criana-ver-tabela-abaixo-esta-dose-no-deve-exceder-a-dose-recomendada-para-o-adulto-que--de-800-miligramas-de-prezista-em-associao-com-150-miligramas-de-cobicistate-ou-100-miligramas-de-ritonavir-uma-vez-por-dia-o-mdico-inform-lo--de-quanto-prezista-suspenso-oral-e-qual-a-quantidade-de-cobicistate-comprimido-ou-ritonavir-cpsulas-comprimidos-ou-soluo-que-a-criana-dever-tomar-peso-corporal-uma-dose-de-prezista--uma-dose-de-ritonavira--uma-dose-de-cobicistate--entre-15-e-30-quilogramas-600-miligramas-6-mililitros-100-miligramas-12-mililitros-no-tomar-entre-30-e-40-quilogramas-675-miligramas-68-mililitros-100-miligramas-12-mililitros-no-tomar-mais-de-40-quilogramas-800-miligramas-8-mililitros-100-miligramas-12-mililitros-150-miligramasb-a-soluo-oral-de-ritonavir-80-miligramas-por-mililitro-b-a-criana-tem-de-ter-idade-igual-ou-superior-a-12-anos-a-criana-deve-tomar-prezista-todos-os-dias-e-sempre-em-combinao-com-150-miligramas-de-cobicistate-ou-100-miligramas-de-ritonavir-e-com-alimentos-prezista-no-atua-adequadamente-sem-cobicistate-ou-ritonavir-e-sem-alimentos-a-criana-dever-comer-uma-refeio-ou-um-lanche-nos-minutos-antes-de-tomar-prezista-e-cobicistate-ou-ritonavir-o-tipo-de-alimentos-no--importante-o-mdico-da-sua-criana-ir-determinar-se-a-sua-criana-deve-tomar-prezista-com-cobicistate-ou-ritonavir-dose-para-crianas-com-idade-igual-ou-superior-a-3-anos-de-idade-que-pesem-pelo-menos-15-quilogramas-e-que-j-tenham-tomado-medicamentos-antirretrovirais-anteriormente-o-mdico-da-sua-criana-ir-determinar-isto-o-mdico-ir-determinar-qual-a-dose-correta-com-base-no-peso-e-idade-da-criana-ver-tabela-abaixo-o-mdico-ir-determinar-qual-a-dose-mais-apropriada-para-a-criana-se-uma-vez-por-dia-se-duas-vezes-por-dia-esta-dose-no-deve-exceder-a-dose-recomendada-para-o-adulto-que--de-600-miligramas-de-prezista-em-associao-com-100-miligramas-de-ritonavir-duas-vezes-por-dia-ou-800-miligramas-de-prezista-em-associao-com-150-miligramas-de-cobicistate-ou-100-miligramas-de-ritonavir-uma-vez-por-dia-o-mdico-inform-lo--de-quanto-prezista-suspenso-oral-e-qual-a-quantidade-de-cobicistate-comprimido-ou-ritonavir-cpsulas-comprimidos-ou-soluo-que-a-criana-dever-tomar-dose-duas-vezes-por-dia-peso-corporal-uma-dose-de-prezista--uma-dose-de-ritonavira--entre-15-e-30-quilogramas-380-miligramas-38-mililitros-50-miligramas-06-mililitros-entre-30-e-40-quilogramas-460-miligramas-46-mililitros-60-miligramas-08-mililitros-mais-de-40-quilogramas-600-miligramas-6-mililitros-100-miligramas-12-mililitros-a-soluo-oral-de-ritonavir-80-miligramas-por-mililitro-dose-uma-vez-por-dia-peso-corporal-uma-dose-de-prezista--uma-dose-de-ritonavira--uma-dose-de-cobicistate--entre-15-e-30-quilogramas-600-miligramas-6-mililitros-100-miligramas-12-mililitros-no-tomar-entre-30-e-40-quilogramas-675-miligramas-68-mililitros-100-miligramas-12-mililitros-no-tomar-mais-de-40-quilogramas-800-miligramas-8-mililitros-100-miligramas-12-mililitros-150-miligramasb-160-a-soluo-oral-de-ritonavir-80-miligramas-por-mililitro-b-a-criana-tem-de-ter-idade-igual-ou-superior-a-12-anos-instrues-para-crianas">Tome
este medicamento exatamente como est descrito neste folheto, ou
conforme indicado pelo seu mdico, farmacutico ou enfermeiro. Fale com
o seu mdico, farmacutico ou enfermeiro se tiver dvidas. Mesmo que se
sinta melhor, no deixe de tomar PREZISTA e cobicistate ou ritonavir sem
falar com o seu mdico. Aps o tratamento ter sido iniciado, a dose ou a
forma de apresentao no devem ser alteradas ou o tratamento no deve
ser interrompido sem indicao do seu mdico. 159 Dose para crianas com
idade igual ou superior a 3 anos que pesem, pelo menos, 15 quilogramas e
que ainda no tenham tomado medicamentos antirretrovirais anteriormente
(o mdico da sua criana ir determinar isto) O mdico ir determinar
qual a dose correta a administrar uma vez por dia com base no peso e
idade da criana (ver tabela abaixo). Esta dose no deve exceder a dose
recomendada para o adulto, que  de 800 miligramas de PREZISTA em
associao com 150 miligramas de cobicistate ou 100 miligramas de
ritonavir, uma vez por dia. O mdico inform-lo- de quanto PREZISTA
suspenso oral e qual a quantidade de cobicistate (comprimido) ou
ritonavir (cpsulas, comprimidos ou soluo) que a criana dever tomar.
Peso corporal: Uma dose de PREZISTA  Uma dose de ritonavira  Uma dose
de cobicistate  entre 15 e 30 quilogramas 600 miligramas (6 mililitros)
100 miligramas (1,2 mililitros) No tomar entre 30 e 40 quilogramas 675
miligramas (6,8 mililitros) 100 miligramas (1,2 mililitros) No tomar
mais de 40 quilogramas 800 miligramas (8 mililitros) 100 miligramas (1,2
mililitros) 150 miligramasb a soluo oral de ritonavir: 80 miligramas
por mililitro b a criana tem de ter idade igual ou superior a 12 anos A
criana deve tomar PREZISTA todos os dias e sempre em combinao com 150
miligramas de cobicistate ou 100 miligramas de ritonavir e com
alimentos. PREZISTA no atua adequadamente sem cobicistate ou ritonavir
e sem alimentos. A criana dever comer uma refeio ou um lanche nos
minutos antes de tomar PREZISTA e cobicistate ou ritonavir. O tipo de
alimentos no  importante. O mdico da sua criana ir determinar se a
sua criana deve tomar PREZISTA com cobicistate ou ritonavir. Dose para
crianas com idade igual ou superior a 3 anos de idade, que pesem, pelo
menos, 15 quilogramas e que j tenham tomado medicamentos
antirretrovirais anteriormente (o mdico da sua criana ir determinar
isto) O mdico ir determinar qual a dose correta com base no peso e
idade da criana (ver tabela abaixo). O mdico ir determinar qual a
dose mais apropriada para a criana, se uma vez por dia, se duas vezes
por dia. Esta dose no deve exceder a dose recomendada para o adulto,
que  de 600 miligramas de PREZISTA em associao com 100 miligramas de
ritonavir, duas vezes por dia ou 800 miligramas de PREZISTA em
associao com 150 miligramas de cobicistate ou 100 miligramas de
ritonavir, uma vez por dia. O mdico inform-lo- de quanto PREZISTA
suspenso oral e qual a quantidade de cobicistate (comprimido) ou
ritonavir (cpsulas, comprimidos ou soluo) que a criana dever tomar.
Dose duas vezes por dia Peso corporal: Uma dose de PREZISTA  Uma dose
de ritonavira  entre 15 e 30 quilogramas 380 miligramas (3,8
mililitros) 50 miligramas (0,6 mililitros) entre 30 e 40 quilogramas 460
miligramas (4,6 mililitros) 60 miligramas (0,8 mililitros) mais de 40
quilogramas 600 miligramas (6 mililitros) 100 miligramas (1,2
mililitros) a soluo oral de ritonavir: 80 miligramas por mililitro
Dose uma vez por dia Peso corporal: Uma dose de PREZISTA  Uma dose de
ritonavira  Uma dose de cobicistate  entre 15 e 30 quilogramas 600
miligramas (6 mililitros) 100 miligramas (1,2 mililitros) No tomar
entre 30 e 40 quilogramas 675 miligramas (6,8 mililitros) 100 miligramas
(1,2 mililitros) No tomar mais de 40 quilogramas 800 miligramas (8
mililitros) 100 miligramas (1,2 mililitros) 150 miligramasb 160 a
soluo oral de ritonavir: 80 miligramas por mililitro b a criana tem
de ter idade igual ou superior a 12 anos Instrues para crianas</h2>
<h2
id="a-criana-tem-de-tomar-sempre-prezista-em-conjunto-com-cobicistate-ou-ritonavir-prezista-no-atua-adequadamente-sem-cobicistate-ou-ritonavir">A
criana tem de tomar sempre PREZISTA em conjunto com cobicistate ou
ritonavir. PREZISTA no atua adequadamente sem cobicistate ou
ritonavir.</h2>
<h2
id="a-criana-deve-tomar-as-doses-apropriadas-de-prezista-e-ritonavir-duas-vezes-por-dia-ou-uma-vez-por-dia-ou-prezista-e-cobicistate-uma-vez-por-dia-se-prezista-for-receitado-duas-vezes-por-dia-a-criana-deve-tomar-uma-dose-de-manh-e-uma-dose-ao-final-da-tarde-o-mdico-da-sua-criana-ir-determinar-qual-o-melhor-regime-de-administrao-da-dose">A
criana deve tomar as doses apropriadas de PREZISTA e ritonavir, duas
vezes por dia ou uma vez por dia ou PREZISTA e cobicistate, uma vez por
dia. Se PREZISTA for receitado duas vezes por dia, a criana deve tomar
uma dose de manh e uma dose ao final da tarde. O mdico da sua criana
ir determinar qual o melhor regime de administrao da dose.</h2>
<h2
id="a-criana-deve-tomar-prezista-com-alimentos-prezista-no-atua-adequadamente-sem-alimentos-o-tipo-de-alimento-no--importante-dose-para-os-adultos-que-no-tenham-tomado-anteriormente-medicamentos-antirretrovirais-o-seu-mdico-determinar-se--aplicvel-no-seu-caso-a-dose-habitual-de-prezista--800-miligramas-uma-vez-por-dia-prezista-deve-ser-tomado-todos-os-dias-e-sempre-em-combinao-com-150-miligramas-de-cobicistate-ou-100-miligramas-de-ritonavir-e-com-alimentos-prezista-no-atua-adequadamente-sem-cobicistate-ou-ritonavir-e-sem-alimentos-dever-comer-uma-refeio-ou-um-lanche-at-30-minutos-antes-de-tomar-prezista-e-cobicistate-ou-ritonavir-o-tipo-de-alimentos-no--importante-mesmo-que-se-sinta-melhor-no-deixe-de-tomar-prezista-e-cobicistate-ou-ritonavir-sem-falar-com-o-seu-mdico-dose-para-os-adultos-que-tenham-tomado-anteriormente-medicamentos-antirretrovirais-o-seu-mdico-determinar-se--aplicvel-no-seu-caso-a-dose-">A
criana deve tomar PREZISTA com alimentos. PREZISTA no atua
adequadamente sem alimentos. O tipo de alimento no  importante. Dose
para os adultos que no tenham tomado anteriormente medicamentos
antirretrovirais (o seu mdico determinar se  aplicvel no seu caso) A
dose habitual de PREZISTA  800 miligramas, uma vez por dia. PREZISTA
deve ser tomado todos os dias e sempre em combinao com 150 miligramas
de cobicistate ou 100 miligramas de ritonavir e com alimentos. PREZISTA
no atua adequadamente sem cobicistate ou ritonavir e sem alimentos.
Dever comer uma refeio ou um lanche at 30 minutos antes de tomar
PREZISTA e cobicistate ou ritonavir. O tipo de alimentos no 
importante. Mesmo que se sinta melhor, no deixe de tomar PREZISTA e
cobicistate ou ritonavir sem falar com o seu mdico. Dose para os
adultos que tenham tomado anteriormente medicamentos antirretrovirais (o
seu mdico determinar se  aplicvel no seu caso) A dose :</h2>
<h2
id="600-miligramas-de-prezista-em-conjunto-com-100-miligramas-de-ritonavir-duas-vezes-por-dia-ou">600
miligramas de PREZISTA em conjunto com 100 miligramas de ritonavir, duas
vezes por dia. OU</h2>
<h2
id="800-miligramas-de-prezista-em-conjunto-com-150-miligramas-de-cobicistate-ou-100-miligramas-de-ritonavir-uma-vez-por-dia-discuta-com-o-seu-mdico-qual-a-dose-mais-indicada-para-si-instrues-para-os-adultos">800
miligramas de PREZISTA em conjunto com 150 miligramas de cobicistate ou
100 miligramas de ritonavir uma vez por dia. Discuta com o seu mdico
qual a dose mais indicada para si. Instrues para os adultos</h2>
<h2
id="tome-sempre-prezista-em-conjunto-com-cobicistate-ou-ritonavir-prezista-no-atua-adequadamente-sem-cobicistate-ou-ritonavir">Tome
sempre PREZISTA em conjunto com cobicistate ou ritonavir. PREZISTA no
atua adequadamente sem cobicistate ou ritonavir.</h2>
<p>Tome PREZISTA com alimentos. PREZISTA no atua adequadamente sem
alimentos. O tipo de alimentos no  importante. Instrues de
utilizao Use a pipeta doseadora fornecida com a embalagem para medir
adequadamente a dose:</p>
<ol type="1">
<li>Agite vigorosamente o frasco antes de cada utilizao.</li>
<li>Abra o frasco de PREZISTA suspenso oral empurrando o fecho com
rosca de plstico para baixo, enquanto o roda no sentido contrrio dos
ponteiros do relgio.</li>
<li>Insira a pipeta doseadora no frasco.</li>
<li>Puxe o mbolo at  linha que corresponde a dose prescrita pelo seu
mdico. 161</li>
<li>Tome a dose de PREZISTA. Coloque a ponta da pipeta doseadora na
boca. Pressione o mbolo da pipeta dentro da boca, e de seguida,
engula.</li>
<li>Aps a utilizao, feche o frasco com a tampa e conserve PREZISTA
suspenso oral conforme indicado na seco 5. 7. Aps cada utilizao,
remova o mbolo da pipeta, e lave com gua deixando secar ao ar.</li>
<li></li>
</ol>
<p>Aps a secagem, coloque a pipeta doseadora novamente na embalagem
juntamente com o frasco de PREZISTA. A pipeta doseadora fornecida no
deve ser utilizada noutros medicamentos. Se tomar mais PREZISTA do que
deveria Contacte imediatamente o seu mdico, farmacutico ou enfermeiro.
Caso se tenha esquecido de tomar PREZISTA Caso tome PREZISTA duas vezes
por dia e se recorde no perodo de 6 horas dever tomar a suspenso oral
imediatamente. Tome sempre o medicamento com ritonavir e com alimentos.
Caso se recorde aps 6 horas, no tome a dose que se esqueceu e tome as
doses seguintes conforme habitual. No tome uma dose a dobrar para
compensar a dose que se esqueceu de tomar. Caso tome PREZISTA uma vez
por dia e se recorde no perodo de 12 horas dever tomar a suspenso
oral imediatamente. Tome sempre o medicamento com cobicistate ou
ritonavir e com alimentos. Caso se recorde aps 12 horas, no tome a
dose que se esqueceu e tome as doses seguintes conforme habitual. No
tome uma dose a dobrar para compensar a dose que se esqueceu de tomar.
Se vomitar aps tomar PREZISTA e cobicistate ou ritonavir Se vomitar
dentro de 4 horas aps a toma do medicamento, deve ser tomada outra dose
de PREZISTA e cobicistate ou ritonavir, com alimentos, logo que
possvel. Se vomitar mais de 4 horas aps a toma do medicamento, no
necessita de tomar outra dose de PREZISTA com cobicistate ou ritonavir
at  prxima dose programada. Contacte o seu mdico se no tiver a
certeza do que fazer, caso se tenha esquecido de tomar uma dose ou se
vomitar. No pare de tomar PREZISTA sem falar previamente com o seu
mdico Os medicamentos anti-VIH podem faz-lo sentir-se melhor. No
deixe de tomar PREZISTA mesmo que se sinta melhor. Fale primeiro com o
seu mdico. Caso ainda tenha dvidas sobre a utilizao deste
medicamento, fale com o seu mdico, farmacutico ou enfermeiro.</p>
 </div>"""         

        
* section[=].section[+]
  * title = "4. Efeitos indesejveis possveis"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Efeitos indesejveis possveis"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2
id="durante-a-teraputica-para-o-vih-pode-haver-um-aumento-do-peso-e-dos-nveis-de-lpidos-e-glucose-no-sangue-isto-est-em-parte-associado-a-uma-recuperao-da-sade-e-do-estilo-de-vida-e-no-caso-dos-lpidos-no-sangue-por-vezes-aos-prprios-medicamentos-para-o-vih-o-seu-mdico-ir-realizar-testes-para-determinar-estas-alteraes-como-todos-os-medicamentos-este-medicamento-pode-causar-efeitos-indesejveis-embora-estes-no-se-manifestem-em-todas-as-pessoas-informe-o-seu-mdico-se-desenvolver-qualquer-dos-seguintes-efeitos-indesejveis-foram-notificados-problemas-de-fgado-que-podem-ocasionalmente-ser-graves-antes-de-iniciar-prezista-o-seu-mdico-dever-pedir-lhe-anlises-ao-sangue-se-tiver-infeo-crnica-por-hepatite-b-ou-c-o-seu-mdico-ir-pedir-lhe-anlises-ao-sangue-mais-frequentemente-visto-que-tem-uma-probabilidade-mais-elevada-de-desenvolver-problemas-de-fgado-fale-com-o-seu-mdico-acerca-dos-sinais-e-sintomas-dos-problemas-de-fgado-estes-podem-incluir-colorao-amarelada-da-pele-ou-da-162-zona-branca-dos-olhos-urina-escurecida-da-cor-do-ch-fezes-de-cor-clara-movimentos-dos-intestinos-nuseas-vmitos-perda-de-apetite-ou-dor-sensao-dolorosa-ou-dor-e-desconforto-do-lado-direito-por-baixo-das-costelas-erupo-na-pele-mais-frequentemente-quando-usado-em-associao-com-raltegravir-comicho-a-erupo-na-pele--geralmente-ligeira-a-moderada-a-erupo-na-pele-pode-tambm-ser-um-sintoma-de-uma-situao-rara-grave--importante-falar-com-o-seu-mdico-se-desenvolver-erupo-na-pele-o-seu-mdico-ir-aconselhar-sobre-como-lidar-com-os-seus-sintomas-ou-se-deve-interromper-o-tratamento-com-prezista-outros-efeitos-indesejveis-graves-incluem-a-diabetes-frequente-e-inflamao-do-pncreas-pouco-frequente-efeitos-indesejveis-muito-frequentes-podem-afetar-mais-de-1-em-cada-10-utilizadores">Durante
a teraputica para o VIH pode haver um aumento do peso e dos nveis de
lpidos e glucose no sangue. Isto est em parte associado a uma
recuperao da sade e do estilo de vida e, no caso dos lpidos no
sangue, por vezes aos prprios medicamentos para o VIH. O seu mdico ir
realizar testes para determinar estas alteraes. Como todos os
medicamentos, este medicamento pode causar efeitos indesejveis, embora
estes no se manifestem em todas as pessoas. Informe o seu mdico se
desenvolver qualquer dos seguintes efeitos indesejveis Foram
notificados problemas de fgado que podem ocasionalmente ser graves.
Antes de iniciar PREZISTA, o seu mdico dever pedir-lhe anlises ao
sangue. Se tiver infeo crnica por hepatite B ou C, o seu mdico ir
pedir-lhe anlises ao sangue mais frequentemente, visto que tem uma
probabilidade mais elevada de desenvolver problemas de fgado. Fale com
o seu mdico acerca dos sinais e sintomas dos problemas de fgado. Estes
podem incluir colorao amarelada da pele ou da 162 zona branca dos
olhos, urina escurecida (da cor do ch), fezes de cor clara (movimentos
dos intestinos), nuseas, vmitos, perda de apetite, ou dor, sensao
dolorosa ou dor e desconforto do lado direito por baixo das costelas.
Erupo na pele (mais frequentemente quando usado em associao com
raltegravir), comicho. A erupo na pele  geralmente ligeira a
moderada. A erupo na pele pode tambm ser um sintoma de uma situao
rara grave.  importante falar com o seu mdico se desenvolver erupo
na pele. O seu mdico ir aconselhar sobre como lidar com os seus
sintomas ou se deve interromper o tratamento com PREZISTA. Outros
efeitos indesejveis graves incluem a diabetes (frequente) e inflamao
do pncreas (pouco frequente). Efeitos indesejveis muito frequentes
(podem afetar mais de 1 em cada 10 utilizadores)</h2>
<h2
id="diarreia-efeitos-indesejveis-frequentes-podem-afetar-at-1-em-cada-10-utilizadores">diarreia.
Efeitos indesejveis frequentes (podem afetar at 1 em cada 10
utilizadores)</h2>
<h2
id="vmitos-nuseas-dor-ou-distenso-abdominal-m-digesto-gases">vmitos,
nuseas, dor ou distenso abdominal, m digesto, gases</h2>
<h2
id="dor-de-cabea-cansao-tonturas-sonolncia-dormncia-formigueiro-ou-dor-nas-mos-ou-ps-falta-de-fora-dificuldade-em-adormecer-efeitos-indesejveis-pouco-frequentes-podem-afetar-at-1-em-cada-100-utilizadores">dor
de cabea, cansao, tonturas, sonolncia, dormncia, formigueiro ou dor
nas mos ou ps, falta de fora, dificuldade em adormecer Efeitos
indesejveis pouco frequentes (podem afetar at 1 em cada 100
utilizadores)</h2>
<h2
id="dor-no-peito-alteraes-no-eletrocardiograma-batimento-rpido-do-corao">dor
no peito, alteraes no eletrocardiograma, batimento rpido do
corao</h2>
<h2
id="sensibilidade-da-pele-diminuda-ou-anormal-sensao-de-picadas-falta-de-ateno-perda-de-memria-problemas-com-o-seu-equilbrio">sensibilidade
da pele diminuda ou anormal, sensao de picadas, falta de ateno,
perda de memria, problemas com o seu equilbrio</h2>
<h2
id="dificuldade-em-respirar-tosse-hemorragia-no-nariz-irritao-da-garganta">dificuldade
em respirar, tosse, hemorragia no nariz, irritao da garganta</h2>
<h2
id="inflamao-do-estmago-ou-boca-azia-nsia-de-vomitar-boca-seca-desconforto-do-abdmen-priso-de-ventre-arroto">inflamao
do estmago ou boca, azia, nsia de vomitar, boca seca, desconforto do
abdmen, priso de ventre, arroto</h2>
<h2
id="insuficincia-renal-pedras-clculos-no-rim-dificuldade-em-urinar-passagem-frequente-ou-excessiva-de-urina-s-vezes-de-noite">insuficincia
renal, pedras (clculos) no rim, dificuldade em urinar, passagem
frequente ou excessiva de urina, s vezes de noite</h2>
<h2
id="urticria-inchao-grave-da-pele-e-outros-tecidos-mais-frequentemente-dos-lbios-ou-dos-olhos-eczema-transpirao-excessiva-suores-noturnos-perda-de-cabelo-acne-pele-descamativa-colorao-das-unhas">urticria,
inchao grave da pele e outros tecidos (mais frequentemente dos lbios
ou dos olhos), eczema, transpirao excessiva, suores noturnos, perda de
cabelo, acne, pele descamativa, colorao das unhas</h2>
<h2
id="dor-muscular-cibras-ou-fraqueza-muscular-dor-nas-extremidades-osteoporose">dor
muscular, cibras ou fraqueza muscular, dor nas extremidades,
osteoporose</h2>
<h2
id="diminuio-da-funo-da-glndula-tiroideia-isto-pode-ser-visualizado-nas-anlises-sanguneas">diminuio
da funo da glndula tiroideia. Isto pode ser visualizado nas anlises
sanguneas.</h2>
<h2 id="presso-arterial-elevada-vermelhido">presso arterial elevada,
vermelhido</h2>
<h2 id="olhos-vermelhos-ou-secos">olhos vermelhos ou secos</h2>
<h2
id="febre-inchao-dos-membros-inferiores-devido-a-reteno-de-fluidos-mal-estar-irritabilidade-dor">febre,
inchao dos membros inferiores devido a reteno de fluidos, mal-estar,
irritabilidade, dor</h2>
<h2 id="sintomas-de-infeo-herpes-simplex">sintomas de infeo, herpes
simplex</h2>
<h2 id="disfuno-ertil-aumento-mamrio">disfuno ertil, aumento
mamrio</h2>
<h2
id="problemas-do-sono-sonolncia-depresso-ansiedade-sonhos-anormais-diminuio-do-desejo-sexual-efeitos-indesejveis-raros-podem-afetar-at-1-em-cada-1000-utilizadores">problemas
do sono, sonolncia, depresso, ansiedade, sonhos anormais, diminuio
do desejo sexual Efeitos indesejveis raros (podem afetar at 1 em cada
1.000 utilizadores)</h2>
<h2
id="reao-chamada-dress-erupo-grave-na-pele-que-pode-ser-acompanhada-de-febre-cansao-inchao-da-face-ou-gnglios-linfticos-aumento-dos-eosinfilos-um-tipo-de-glbulos-brancos-efeitos-no-fgado-rins-ou-pulmes">reao
chamada DRESS [erupo grave na pele, que pode ser acompanhada de febre,
cansao, inchao da face ou gnglios linfticos, aumento dos eosinfilos
(um tipo de glbulos brancos), efeitos no fgado, rins ou pulmes]</h2>
<h2 id="ataque-cardaco-batimento-lento-do-corao-palpitaes">ataque
cardaco, batimento lento do corao, palpitaes</h2>
<h2 id="perturbao-visual">perturbao visual</h2>
<h2 id="arrepios-sensao-anormal">arrepios, sensao anormal</h2>
<h2
id="sensao-de-confuso-ou-desorientao-alterao-do-humor-agitao">sensao
de confuso ou desorientao, alterao do humor, agitao</h2>
<h2
id="desmaio-convulses-epilticas-alteraes-ou-perda-de-paladar">desmaio,
convulses epilticas, alteraes ou perda de paladar</h2>
<h2
id="lceras-na-boca-vomitar-sangue-inflamao-dos-lbios-lbios-secos-lngua-saburrosa">lceras
na boca, vomitar sangue, inflamao dos lbios, lbios secos, lngua
saburrosa</h2>
<h2 id="corrimento-nasal">corrimento nasal</h2>
<h2 id="leses-na-pele-pele-seca">leses na pele, pele seca</h2>
<h2
id="rigidez-nos-msculos-ou-articulaes-dor-nas-articulaes-com-ou-sem-inflamao-163">rigidez
nos msculos ou articulaes, dor nas articulaes com ou sem inflamao
163</h2>
<h2
id="alteraes-em-determinados-valores-bioqumicos-ou-das-suas-clulas-sanguneas-estas-podem-ser-observadas-nos-resultados-das-anlises-ao-sangue-eou-urina-o-seu-mdico-ir-explic-las-exemplos-incluem-o-aumento-de-alguns-glbulos-brancos">alteraes
em determinados valores bioqumicos ou das suas clulas sanguneas.
Estas podem ser observadas nos resultados das anlises ao sangue e/ou
urina. O seu mdico ir explic-las. Exemplos incluem o aumento de
alguns glbulos brancos</h2>
<h2
id="cristais-de-darunavir-no-rim-provocando-doena-renal-alguns-efeitos-indesejveis-so-tpicos-de-medicamentos-anti-vih-da-mesma-famlia-que-prezista-estes-so">cristais
de darunavir no rim, provocando doena renal. Alguns efeitos
indesejveis so tpicos de medicamentos anti-VIH da mesma famlia que
PREZISTA. Estes so:</h2>
<p>dor, sensibilidade ou fraqueza muscular. Em casos raros, estas
perturbaes musculares foram graves. Comunicao de efeitos
indesejveis Se tiver quaisquer efeitos indesejveis, incluindo
possveis efeitos indesejveis no indicados neste folheto, fale com o
seu mdico, farmacutico ou enfermeiro. Tambm poder comunicar efeitos
indesejveis diretamente atravs do sistema nacional de notificao
mencionado no Apndice V. Ao comunicar efeitos indesejveis, estar a
ajudar a fornecer mais informaes sobre a segurana deste
medicamento.</p>
 </div>"""      
        
* section[=].section[+]
  * title = "5. Como conservar prezista"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. Como conservar prezista"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Manter este medicamento fora da vista e do alcance das crianas. No
utilize este medicamento aps o prazo de validade impresso na embalagem
exterior e no frasco, aps VAL. O prazo de validade corresponde ao
ltimo dia do ms indicado. Conservar a temperatura inferior a 30C. No
refrigerar ou congelar. Evitar a exposio excessiva ao calor. Conservar
na embalagem de origem. No deite fora quaisquer medicamentos na
canalizao ou no lixo domstico. Pergunte ao seu farmacutico como
deitar fora os medicamentos que j no utiliza. Estas medidas ajudaro a
proteger o ambiente.</p>
 </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contedo da embalagem e outras informaes"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contedo da embalagem e outras informaes"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <h2 id="qual-a-composio-de-prezista">Qual a composio de
PREZISTA</h2>
<h2
id="a-substncia-ativa--darunavir-cada-mililitro-contm-100-miligramas-de-darunavir-sob-a-forma-de-etanolato">A
substncia ativa  darunavir. Cada mililitro contm 100 miligramas de
darunavir (sob a forma de etanolato).</h2>
<p>Os outros componentes so hidroxipropilcelulose, celulose
microcristalina e carmelose sdica, cido ctrico monohidratado,
sucralose, aroma de morango, corretor de sabor, para- hidroxibenzoato de
metilo sdico (E219), cido clordrico (para ajuste do pH) e gua
purificada. Qual o aspeto de PREZISTA e contedo da embalagem Suspenso
oral esbranquiada opaca. Frasco de vidro de cor mbar multidose para
200 ml de suspenso, com fecho de polipropileno resistente  abertura
por crianas e com uma pipeta doseadora de 6 ml, graduada em 0,2 ml, de
polietileno de baixa densidade (LDPE). A parte superior do frasco 
preenchida por uma insero de polietileno de baixa densidade (LDPE),
que acomoda a pipeta doseadora. A pipeta doseadora fornecida no deve
ser utilizada noutros medicamentos. PREZISTA est tambm disponvel nas
dosagens de 75 miligramas, 150 miligramas, 400 miligramas, 600
miligramas e 800 miligramas na forma de comprimidos revestidos por
pelcula. Titular da Autorizao de Introduo no Mercado Janssen-Cilag
International NV, Turnhoutseweg 30, B-2340 Beerse, Blgica Fabricante
Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, Blgica
164 Para quaisquer informaes sobre este medicamento, queira contactar
o representante local do Titular da Autorizao de Introduo no
Mercado: Belgi/Belgique/Belgien Janssen-Cilag NV Tel/Tl: +32 14 64 94
11 <a href="mailto:janssen@jacbe.jnj.com">janssen@jacbe.jnj.com</a>
Lietuva UAB "JOHNSON &amp; JOHNSON" Tel: +370 5 278 68 88 <a
href="mailto:lt@its.jnj.com">lt@its.jnj.com</a>   &amp;
 "  .: +359 2 489 94 00 <a
href="mailto:jjsafety@its.jnj.com">jjsafety@its.jnj.com</a>
Luxembourg/Luxemburg Janssen-Cilag NV Tl/Tel: +32 14 64 94 11 <a
href="mailto:janssen@jacbe.jnj.com">janssen@jacbe.jnj.com</a> esk
republika Janssen-Cilag s.r.o. Tel: +420 227 012 227 Magyarorszg
Janssen-Cilag Kft. Tel.: +36 1 884 2858 <a
href="mailto:janssenhu@its.jnj.com">janssenhu@its.jnj.com</a> Danmark
Janssen-Cilag A/S Tlf: +45 4594 8282 <a
href="mailto:jacdk@its.jnj.com">jacdk@its.jnj.com</a> Malta AM MANGION
LTD Tel: +356 2397 6000 Deutschland Janssen-Cilag GmbH Tel: +49 2137 955
955 <a href="mailto:jancil@its.jnj.com">jancil@its.jnj.com</a> Nederland
Janssen-Cilag B.V. Tel: +31 76 711 1111 <a
href="mailto:janssen@jacnl.jnj.com">janssen@jacnl.jnj.com</a> Eesti UAB
"JOHNSON &amp; JOHNSON" Eesti filiaal Tel: +372 617 7410 <a
href="mailto:ee@its.jnj.com">ee@its.jnj.com</a> Norge Janssen-Cilag AS
Tlf: +47 24 12 65 00 <a
href="mailto:jacno@its.jnj.com">jacno@its.jnj.com</a> 
Janssen-Cilag  .... T: +30 210 80 90 000 sterreich
Janssen-Cilag Pharma GmbH Tel: +43 1 610 300 Espaa Janssen-Cilag, S.A.
Tel: +34 91 722 81 00 <a
href="mailto:contacto@its.jnj.com">contacto@its.jnj.com</a> Polska
Janssen-Cilag Polska Sp. z o.o. Tel.: +48 22 237 60 00 France
Janssen-Cilag Tl: 0 800 25 50 75 / +33 1 55 00 40 03 <a
href="mailto:medisource@its.jnj.com">medisource@its.jnj.com</a> Portugal
Janssen-Cilag Farmacutica, Lda. Tel: +351 214 368 600 Hrvatska Johnson
&amp; Johnson S.E. d.o.o. Tel: +385 1 6610 700 <a
href="mailto:jjsafety@JNJCR.JNJ.com">jjsafety@JNJCR.JNJ.com</a> Romnia
Johnson &amp; Johnson Romnia SRL Tel: +40 21 207 1800 165 Ireland
Janssen Sciences Ireland UC Tel: +353 1 800 709 122 Slovenija Johnson
&amp; Johnson d.o.o. Tel: +386 1 401 18 00 <a
href="mailto:Janssen_safety_slo@its.jnj.com">Janssen_safety_slo@its.jnj.com</a>
sland Janssen-Cilag AB c/o Vistor hf. Smi: +354 535 7000 <a
href="mailto:janssen@vistor.is">janssen@vistor.is</a> Slovensk
republika Johnson &amp; Johnson, s.r.o. Tel: +421 232 408 400 Italia
Janssen-Cilag SpA Tel: 800.688.777 / +39 02 2510 1 <a
href="mailto:janssenita@its.jnj.com">janssenita@its.jnj.com</a>
Suomi/Finland Janssen-Cilag Oy Puh/Tel: +358 207 531 300 <a
href="mailto:jacfi@its.jnj.com">jacfi@its.jnj.com</a>  
  : +357 22 207 700 Sverige Janssen-Cilag AB Tfn: +46
8 626 50 00 <a href="mailto:jacse@its.jnj.com">jacse@its.jnj.com</a>
Latvija UAB "JOHNSON &amp; JOHNSON" filile Latvij Tel: +371 678 93561
<a href="mailto:lv@its.jnj.com">lv@its.jnj.com</a> United Kingdom
(Northern Ireland) Janssen Sciences Ireland UC Tel: +44 1 494 567 444
Este folheto foi revisto pela ltima vez em MM/AAAA Est disponvel
informao pormenorizada sobre este medicamento no stio da internet da
Agncia</p>
 </div>"""      





                    
Instance: bundlepackageleaflet-en-c73255ba16f112f8e9f93b50083ae06f
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for prezista Package Leaflet for language en"
Description: "ePI document Bundle for prezista Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-c73255ba16f112f8e9f93b50083ae06f"
* entry[0].resource = composition-en-c73255ba16f112f8e9f93b50083ae06f

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpc73255ba16f112f8e9f93b50083ae06f"
* entry[=].resource = mpc73255ba16f112f8e9f93b50083ae06f
                            
                    
Instance: bundlepackageleaflet-da-c73255ba16f112f8e9f93b50083ae06f
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for prezista Package Leaflet for language da"
Description: "ePI document Bundle for prezista Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-c73255ba16f112f8e9f93b50083ae06f"
* entry[0].resource = composition-da-c73255ba16f112f8e9f93b50083ae06f

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpc73255ba16f112f8e9f93b50083ae06f"
* entry[=].resource = mpc73255ba16f112f8e9f93b50083ae06f
                            
                    
Instance: bundlepackageleaflet-pt-c73255ba16f112f8e9f93b50083ae06f
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for prezista Package Leaflet for language pt"
Description: "ePI document Bundle for prezista Package Leaflet for language pt"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #pt

// Composition
* entry[0].fullUrl = "Composition/composition-pt-c73255ba16f112f8e9f93b50083ae06f"
* entry[0].resource = composition-pt-c73255ba16f112f8e9f93b50083ae06f

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpc73255ba16f112f8e9f93b50083ae06f"
* entry[=].resource = mpc73255ba16f112f8e9f93b50083ae06f
                            
                    



Instance: mpc73255ba16f112f8e9f93b50083ae06f
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product PREZISTA 100 mg/ml oral suspension"
Description: "PREZISTA 100 mg/ml oral suspension"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/06/380/006"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "PREZISTA 100 mg/ml oral suspension"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: c73255ba16f112f8e9f93b50083ae06fListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "prezista"

* status = #current
* mode = #working

* title = "List of all ePIs associated with prezista"

* subject = Reference(mpc73255ba16f112f8e9f93b50083ae06f)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#prezista "prezista"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-c73255ba16f112f8e9f93b50083ae06f) // prezista en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-c73255ba16f112f8e9f93b50083ae06f) // prezista da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"



* entry[+]
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-pt-c73255ba16f112f8e9f93b50083ae06f) // prezista pt
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "pt"




Instance: List-c73255ba16f112f8e9f93b50083ae06f
InstanceOf: List
Description: "ePI document List for prezista Package Leaflets"

* insert c73255ba16f112f8e9f93b50083ae06fListRuleset
    